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Abstract 
   Toxoplasma gondii is an obligate intracellular parasite that is estimated to infect 
one third of the world’s human population. Upon infection this parasite causes the 
disease toxoplasmosis which in most healthy humans is chronic and often 
asymptomatic. If infection occurs in a human host without a competent immune 
system such as an unborn baby or infant or someone suffering from AIDS, 
toxoplasmosis can lead to permanent disability or death. A growing amount of 
evidence indicates a statistical relationship between chronic infection in healthy 
adults and neurological disorders leading to behavioural and psychological 
problems. 
   Toxoplasma gondii can be spread through contact with cat faeces. This was 
thought to be the main mode of human infection. Subsequent testing with murine 
and Felidae models has shown that the bradyzoite of Toxoplasma gondii within 
intracellular cysts in muscle and neural tissue are far more infectious than the 
oocyst morphology shed in cat faeces. This indicates that consumption of infected 
meat products may also play a major contributing role in the world’s high rate of 
toxoplasmosis infection. 
   The chief aim of this study was to develop a sensitive PCR assay to detect the 
presence of Toxoplasma gondii in fresh raw meat products. Beef, chicken, lamb 
and pork mince were chosen as convenient forms of fresh raw meat as each pack 
available for purchase contains the meat from several animal’s tissues (increasing 
the likelihood of contamination) and it has been partially homogenised allowing 
for easier sampling and DNA extraction. 
   Secondary aims of this study were to evaluate PCR primer sets targeting 
polymorphic regions to gain some understanding of what strains of 
Toxoplasma gondii are present in our meat and the prevalence in the local cat 
populations. 
   To accomplish these aims positive and negative PCR controls were also 
developed using a live toxoplasmosis vaccine and DNA extracted from Zebrafish. 
DNA extraction techniques were developed to purify DNA from both muscle 
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tissue and feline faecal samples and primer sets were selected from published 
literature as well as designed using NCBI primer BLAST.    
   Toxoplasma gondii specific DNA was detected in only one of the 25 meat 
samples purchased. This was achieved using a primer set targeting the P30 region 
of the SAG1 gene and confirmed by DNA sequencing. 
   Using primer sets targeting polymorphic sites within the Toxoplasma gondii 
genome, sequencing and restriction enzyme digests it was shown that 
Toxoplasma gondii present in the feral Felis catus population in the raglan area is 
type II at the GRA6 and SAG3 loci. Amplification of polymorphic PCR targets 
from DNA extracted from meat samples could not be achieved. 
   Non-specific amplification occurred with a majority of primer sets trialled with 
meat DNA extracts indicating improvements are needed in primer design for the 
purpose of PCR detection of Toxoplasma gondii in meat. Nested PCR increased 
specificity however resulted in contamination in several instances. 
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Chapter One 
Literature Review  
 
1.1 Introduction 
 
   Toxoplasma gondii is an protozoan obligate intracellular parasite that infects a 
wide range of wild and domestic warm-blooded animals worldwide (Su et al., 
2012). The primary hosts for T. gondii are the members of the felidae family 
including domestic and feral Felis silvestris catus. This parasite belongs belongs 
to the phylum Apicomplexa, subclass Coccidiasina and family Sarcocystidae and 
is responsible for the disease toxoplasmosis.  
   T. gondii was first described in 1908 after its discovery in the common gundi 
(Ctenodactylus gundi), a species of rodent (from which the term gondii is derived) 
(Nicolle & Manceaux, 1908). It was not until 1970 that oocysts were first found in 
felidae feaces and the full life cycle of T. gondii could be described (J. Dubey, 
2009) (see Figure 1.1 below).  
   It is within the intestinal walls of a primary (filidae) host that T. gondii is able to 
complete sexual recombination (Figure 1.1) and it is the only region where it is 
able to form a diploid  state, in its other morphologies (tachyzoites, bradyzoites 
and oocysts) T. gondii exists only in a haploid state (Figure 1.2).  
  In (primary) felidae hosts the parasite undergoes sexual reproduction (and 
recombination) in the epithelial cells lining the small intestine. This process is 
known as merogony (Figure 1.1), where merozoites replicate within enterocyte 
cells in the intestinal cell wall to produce gametes which are able to recombine 
giving rise to oocysts (Hunter & Sibley, 2012b). Oocysts are shed in fealidae 
faeces during a period of around two weeks between one and three weeks 
following infection. Upon shedding oocysts undergo sporylation creating a 
durable capsule that allows the oocysts to survive in soil and in water tables for 
prolonged periods of time.  
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Figure 1.1 Life cycle of Toxoplasma gondii (Hunter & Sibley, 2012b) 
 
 
Figure 1.2 Schematic diagrams of Toxoplasma gondii morphologies. 
Tachyzoite (left), bradyzoite (centre), Sporozoite (right) (J. Dubey, Lindsay, & 
Speer, 1998). The localisation of the microneme, rhoptry, and dense granules are 
depicted.  
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1.2 Toxoplasma gondii infection 
 
   There are multiple potential routes of T. gondii infection. Consumption of 
contaminated meat containing bradyzoite cysts is thought to be the major cause of 
human infection. Alternatively, zoonotic transmission can occur after accidental 
ingestion of oocysts from cat faeces after cleaning a cat's litter box or gardening. 
Oocysts can survive in water tables and therefore can be contracted within 
drinking water. Contaminated water runoff is the likely source of oocysts found in 
mussel populations are thought to be a cause of otter and seal infections (Miller et 
al., 2008). Toxoplasmosis can also be contracted though blood transfusion and 
organ transplant and perhaps most dangerous to humans is congenital contraction 
where tachyzoites pass from the bloodstream of an infected mother to unborn 
child through the placental walls. 
   Infection with T. gondii is pervasive and potentially deadly in both animal and 
human hosts. Healthy humans infected by T. gondii may experience flu-like 
symptoms during the initial (acute) phase of the infection, however unborn 
children, cancer patients, AIDS and other patients without normal immune system 
function can quickly become seriously ill and die from rampant T. gondii 
infection.  
   New Zealand has a higher than average rate of chronic T. gondii infection (Lake 
et al., 2002; Zarkovic et al., 2007). A national serological study carried out in 
2009 showed that aproxamately 20% of New Zealanders aged between 16 and 24 
and 30% of New Zealanders aged between 25 and 44 have been exposed to 
Toxoplasma gondii (Weir, Jennings, Young, Brunton, & Murdoch, 2009). In 
2002, the New Zealand Food Safety Authority carried out an assessment of the 
potential risk of contracting toxoplasmosis from contaminated meat. No 
information on the risk of infection from New Zealand meat products was 
available at that time (Lake et al., 2002). 
   According to the Centre for Disease Control (CDC), toxoplasmosis is the 
second most common foodborne killer in USA next to salmonella. It is estimated 
that 50% of these cases are due to consumption of contaminated food (Bayarri, 
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Gracia, Lázaro, Pérez-Arquillué, & Herrera). In New Zealand, between 2000 and 
2006, congenital toxoplasmosis caused three deaths with seven cases discharged 
from hospital (ESR, 2010). During this same period, thousands of individuals 
would have contracted chronic toxoplasmosis but would only have noticed mild 
flu-like symptoms, if any. 
   Although it is often considered asymptomatic, chronic T. gondii infection causes 
increased levels of the neurotransmitter dopamine and the hormone testosterone. 
Chronic toxoplasmosis has been linked to increased aggressive behaviour and 
increased rates of mental illness such as schizophrenia, manic-depression, 
obsessive compulsive disorder, depressive states and other mental illnesses 
(Fekadu, Shibre, & Cleare, 2010; Jarolslav Flegr, 2013). Chronic T. gondii 
infection has also been linked with an increased rates of motor vehicle accident, 
with one study finding that T. gondii seropositive individuals are 2.3 times more 
likely to be involved in a car accident (Kocazeybek et al., 2009). 
 
1.3 Host cell invasion 
 
   Although T. gondii has no flagellum, independent motility is achieved through 
writhing and actin-myosin powered mechanisms (Meissner, Schlüter, & Soldati, 
2002). Upon contact with a target host cell an orchestrated cascade of secretion 
from three structurally and biochemically distinct organelles; the micronemes, 
rhoptries and dense granules (Figure 1.2). This facilitates parasitic invasion, the 
formation of a parasitiphorous vacuole (PV) and uptake of nutrients into the PV 
and protection from host cell immune responses (Figure 1.3). Host cell entry of 
the parasite is completed in 15–20 seconds (SAFFER, MERCEREAU‐
PUIJALON, DUBREMETZ, & SCHWARTZMAN, 1992). 
   Fusion with the host cell membrane occurs at the apical tip of the invading 
parasite. When this occurs, micronemes discharge their contents. Many of these 
proteins are predicted to be membrane associated, some of which target the host 
cell membrane and some of which remain lodged in the cell membrane of the 
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parasite. These factors are thought to play essential roles in creation of a moving 
junction ie., the interface between the host cell membrane and the developing PV 
that will completely enclose the parasite following invasion. This moving junction 
also provides a point of attachment for actin-myosin ‘motors’ that propel the 
parasite further into the host cell. 
   The club-shaped rhoptries are the next secretory organelle to discharge proteins 
from the apical tip of the invading parasite directly into the cytoplasm of the host 
cell. There are approximately 8–12 rhoptries per cell, occupying 10–30% of the 
total cell volume. They are the only known acidified organelles in T. gondii with a 
pH ranging from 3.5 to 7.0 (Weir et al., 2009). Known functions of rhoptry 
proteins are facilitation of biogenesis of the parasitophorous vacuole (PV) and 
host-PV interactions. These factors/enzymes/proteins have also been observed to 
play essential roles in supressing host cell immune responses.  
 
Figure 1.3 Toxoplasma gondii invasion of a host cell, formation of the 
parasitophorous vacuole and deployment of rhoptry proteins (Hunter & 
Sibley, 2012b). PV = parasitophorous vacuole; ROP = rhoptry protein; RON = 
rhoptry neck protein. 
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   Dense granules are the last of the secretory organelles to release their contents. 
These enter the parasitiphorous vacuole once formed and are thought to facilitate 
the uptake of nutrients from within the cytoplasm of the host cell into the 
parasitiphorous vacuole. Dense granule proteins may also play a role in 
suppressing host immune responses and also inducing changes in host 
neurological function.  
   Once within the intestine of a secondary host (prey such as mice and birds or 
other warm blooded animals) the parasite reproduces as rapidly dividing 
tachyzoites which replicate in a clonal manor known as endodyogeny until 
causing host cell lysis and release of the tachyzoites contained within. Once 
tachyzoites reach the host circulatory system circulatory system they become are 
distributed throughout almost all the host’s tissues. By invasion of leukocytes and 
manipulating gene expression, tachyzoites are able to penetrate through ordinarily 
impermeable membranes and barriers (such as the blood brain barrier) into almost 
all of bodies tissue, particularly the central nervous system and skeletal muscle. 
(Weidner & Barragan, 2014)  
 
1.4 Development and perpetuation of chronic infection 
 
   As the host immune response becomes effective against the invading 
tachyzoites a small fraction of those tachyzoites differentiate into a much more 
slowly replicating bradyzoite morphology. These persist within intracellular cysts 
that can contain upto several thousand bradyzoites (Hunter & Sibley, 2012a) 
within a paracitophorous vacuole that is able to protect the encysted bradyzoites 
from intracellular immune responses (Hunter & Sibley, 2012a). 
   Immunoprivaleged tissues such as nervous and muscle tissues are most 
susceptible to cyst formation. These cysts  are able to mask themselves from host 
immune responses through the formation of parasitiphorous vacuoles, organelle 
like membrane bound vesicles which are derived in part from host cell membrane 
(Figure 1.4) and through manipulation of host gene expression, inflammatory 
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responses, and intracellular immune response mechanisms via secretion of various 
proteins and enzymes (Melo, Jensen, & Saeij, 2011) (Zhou et al., 2005). 
 
Figure 1.4 A bradyzoite cyst isolated from a mouse brain. The arrow shows 
the parasitiphous vacuole membrane (J. Dubey et al., 1998). 
 
   Through comparison of differential gene expression, polymorphisms between 
various T. gondii strains and genetic manipulation in concert with murine studies, 
researchers have demonstrated the function of numerous proteins responsible for 
TG virulence. For example, enzymes such as Rhoptry proteins. 
   Rhoptry protein RHOP18 is a kinase that inhibits interferon gamma IFNγ 
mediated killing of intracellular toxoplasma through phosphorylation of a 
nucleotide binding site of interferon regulated guanine triphosphatases (GTPases) 
(Melo et al., 2011). Other NTPases have also been observed to affect Toxoplasma 
virulence (Asai, Miura, Sibley, Okabayashi, & Takeuchi, 1995). Although the 
mechanism for this is unclear, it has been proposed that NTPases may reduce the 
amount of ATP available for induction of pyroapoptosis though activation of 
Nlrp3 inflammasome (Melo et al., 2011; Schroder & Tschopp, 2010). An 
inflammasome is a multiprotein oligomer. 
   RHOP5 is a duplicated polymorphic psuedokinase with the 
isoform/polymorphism is estimated to be responsible for 90% of the variance in 
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virulence between strains in murine models. The mechanism by which RHOP5 
effects virulence is unknown but knockout studies show its presence or absence 
has no effect on invasion, PV formation, nutrient uptake, replication or egress 
from host cells (Reese, Zeiner, Saeij, Boothroyd, & Boyle, 2011). 
   ROP16 and dense granule protein GRA15 have both been observed to effect 
host cell gene transcription. Polymorphisms of ROP16 were observed to have a 
significant effect on T. gondii  virulence. The mechanisms by which ROP16 
affects virulence is unclear but ROP16 is known to stimulate STAT3 and STAT6 
(signal transducers and activators of transcription) (Ong, Reese, & Boothroyd, 
2010; Yamamoto et al., 2009). STAT3 is able to inhibit NF-κβ, transcription 
factors that play important roles in regulation of immune responses and may be 
one of the mechanisms responsible. ROP16 has also been detected within host cell 
nuclei suggesting that it may play other important roles in manipulating host gene 
expression.  
   Study of polymorphisms of the dense granule protein GRA15 has shown that 
this protein can modulate NF-κβ activation. GRA15 from the archetypal type II 
lineage shows significantly higher levels of NF-κβ activation leading to IL-12 
(interleukin 12) and other pro-inflammatory cytokine synthesis than other GRA15 
analogues (Robben et al., 2004; Rosowski et al., 2011).  
 
1.5 The Toxoplasma gondii genome 
 
   The Toxoplasma gondii genome consists of 14 chromosomes containing 
approximately 65 million bases (Figure 1.8) ranging in size from 2 to 7 Mb, a 35 
thousand base apicoplast circular chromosome as well as mitochondrial DNA. 
The number for genes is estimated to be 7793 (Khan et al., 2005). 
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Figure 1.5 Linkage map of the 14 chromosomes of Toxoplasma gondii (Khan 
et al., 2005). 
 
1.6 Population Genetics 
 
   Important with regard to the population genetics of T. gondii is that without 
ingestion by felidae, merogogy cannot occur and the parasite is only able to 
reproduce in a clonal mode, with evolution occurring only through random 
mutation. The rate at which random mutations occur within T. gondii subspecies 
and morphologies is an unknown and comlicating factor when considering its 
evolutionary history (Wendte, Gibson, & Grigg, 2011).  
   Significant genetic changes occur only when localised sub-species (largely 
clonal lineages) are able to recombine and evolve through independent assortment 
(admixture) when merogogy of two (or more) infections occur simultaneously 
within the intestine of the primary host. This could be a result of ingestion of 
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multiple prey animals or prey animals with infections of multiple T. gondii 
subspecies. 
   T. gondii subspecies all originate from three or four archetypal lineages that 
originated in South America and spread to North America and Europe around 
10,000 years ago (Figure 1.5). Within South America greater genetic variation of 
T. Gondii has been observed than outside of South America where genotyping 
studies indicate all subspecies variation is a result of admixture of the three 
common T. gondii subspecies known (types i, ii, and iii) (Minot et al., 2012). 
There is a variance among these subspecies in virulence, due to differences in the 
way in which each subspecies interferes with host immune systems. This is due to 
differences in levels of secreted kinase and psuedokinase enzymes that the 
parasite employs to interfere with immune response systems and gene expression 
of host cells. 
   The importance of gaining an accurate measure of how we (New Zealanders and 
humans) contract toxoplasmosis cannot be underestimated. The parasite causes 
infant mortality, lifelong disease and is likely to contribute rates of mental illness 
and road toll. The effects on behaviour combined with the high rate of infection 
may have significant effects on community wellbeing. 
   The opening of global shipping lanes appears to have stimulated significant 
diversification of T. gondii subspecies through the transportation of infected mice, 
rats and cats from continent to continent. The result of this admixture can be 
observed in studies of global T. gondii diversity such as ‘Globalisation and 
population structure of T. gondii’ (Lehmann, Marcet, Graham, Dahl, & Dubey, 
2006). 
   Phylogenetic analysis of T. gondii isolates have shown that the current global 
genetically (and morphologically) diverse distribution of T. gondii subspecies 
originated from a small number (likely four) ancestral lineages (Fig.1.5) which 
over recent centuries have recombined to give various localised populations. (Fig. 
1.6) (Khan et al., 2005; Minot et al., 2012; Sibley, Khan, Ajioka, & Rosenthal, 
2009; Su et al., 2012; Wendte et al., 2011). 
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Figure 1.6. Estimated global distribution of Toxoplasma gondii lineages 
derived from phylogenetic analysis of eleven chromosome 1a haplotype blocks 
(Khan et al., 2006; Sibley et al., 2009). 
 
 
Figure 1.7 Global distribution of subspecies variation. This proposed model 
related to four ancient clonal lineages; two from South America (SA1 and SA2), 
one distributed throughout the rest of the world (RW), and one distributed 
worldwide (WW) (Lehmann et al., 2006). 
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1.7 Global distribution: 
 
   It is estimated that approximately one third of the world’s population is thought 
to be infected with chronic toxoplasmosis but survey results of local infection 
rates around the world vary widely, from up to 100% in some areas in Brazil to 
0% in parts of northern Europe (Pappas, Roussos, & Falagas, 2009). 
 
Figure 1.8 Global status of Toxoplasma gondii seroprevalance. Colour shading 
represents prevalence levels: Dark red: greater than 60%; Light red: from 40% to 
60%; Yellow: from 20% to 40%; Blue: 10% to 20%; Green: less than 10%; white: 
absence of data (Pappas et al., 2009). 
 
1.8 Methodology used to detect T. gondii  
 
   Seroepidemiological methods can detect whether humans or animals have been 
exposed to T. gondii  using the Sabin-Feldman Dye Test developed in 1949 
(Grillo et al., 1999) and the enzyme linked immunosorbent assay (ELISA) or the . 
The Sabin-Feldman Dye Test is the gold-standard for detection of chronic 
T. gondii infection. T. gondii cells are incubated in (test) serum. If 
immunoglobulin G (IgG) antibodies are present in the test serum, they will cause 
lysis of the parasite cells. To test whether lysis has occurred, the nuclear stain 
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methylene blue is applied. If cell lysis has occurred, the stain will be able to 
access the parasite nucleus and therefore stain the cells blue. If lysis has not 
occurred, the parasite remains unstained. ELISA involves the detection of anti-
T. gondii antibodies on plastic plates coated with T. gondii surface proteins 
(antigenic proteins) or surface polysacharides. Anti-T. gondii antibodies bind to 
these targets and can then visualised (and potentially quantified) using enzyme 
linked or fluorescently labelled secondary antibodies (that bind to the heavy chain 
end of the anti T. gondii antibodies. This technique is useful for detecting chronic 
T. gondii infection where no parasite DNA is available and using quantification 
methods can also give an indication of the length of time since infection as 
antibody concentration will increases over time. In comparison, these two 
techniques are unable to determine the subspecies of a chronic T. gondii infection. 
To achieve this, a sample containing tachyzoites or bradyzoite cysts is required. 
   Polymerase chain reaction (PCR) detection methods can be used to detect active 
tachyzoite infection as live parasite is present within the bloodstream, and other 
fluids including amneotic and cerebrospinal fluid. These situations occur when the 
host’s immune response is either compromised pharmaceutically, for example 
with immunosuppressant drugs for organ transplant recipients, through infection 
(typically due to AIDS) or due to underdevelopment in the case of congenital or 
early childhood infection (Costa et al., 2013). 
   Although more difficult and more invasive, PCR methods can be used to detect 
chronic T. gondii infection in both muscle and neural tissue and could potentially 
also be used to analyse the subspecies present (Jauregui, Higgins, Zarlenga, 
Dubey, & Lunney, 2001). This would be advantageous for physicians treating 
these cases as genotyping can give valuable insights into the virulence and 
antibiotic resistance and/or susceptibility (Aspinall, Marlee, Hyde, & Sims, 2002) 
of the infection and hence assist in choosing the optimal course of treatment. A 
variety of treatment options are used for acute toxoplasmosis infection, strategies 
vary widely depending on the way in which toxoplasmosis presents, (ie: 
prenatal/neonatal/ocular/cerebral lesions) these strategies generally consist of 
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prolonged high doses of a variety of antibiotics but may include surgical options 
such as drainage where encephalitis has occurred. 
   As a diagnostic tool, PCR reactions employing primers to target genomic DNA 
repeat regions such as B1 gene and 529-bp repeat element AF146527 provide high 
sensitivity. B1 is thought to be repeated between 2.5 and 10.2 times (relative to 
the single copy target, P30)(Costa & Bretagne, 2012) within the toxoplasmosis 
genome and AF146527 between 21.1 and 64.3 times(Costa & Bretagne, 2012). 
There can be significant variation in copy number depending upon the type and 
strain of T. gondii infection (Costa & Bretagne, 2012; Reischl, Bretagne, Krüger, 
Ernault, & Costa, 2003). 
   Nested PCR techniques are generally used for amplification of single copy 
targets due to their high specificity and amplification power. Nested PCR employs 
a second set of “internal” primers to amplify a specific region from within the 
product or products from the “outer” set.  
   A study of human blood donors from the Waikato region in 2007 gave an 
estimated infection rate of 42.9% ± 8% (Zarkovic et al., 2007), but infection rates 
among the general population may be even higher. In a study by RTM Cursons et 
al. at Waikato hospital, infection rates among pregnant women were measured at 
between 58.5% (15-20 yrs old) and 68.5% (31-35yrs old) (Lake, Hudson, & 
Cressey, 2002). 
   T. gondii has generally been associated with exposure to cat faeces but studies 
overseas have shown that consumption of undercooked infected meat may be a 
major contributor to the rate of human infection. For example a UK study 
(Aspinall et al., 2002) found 38% of their samples of 71 different meat products 
were contaminated with T. gondii.  
   Because T. gondii isolates itself from the circulatory system by forming 
intracellular cysts it is impossible to determine which subspecies has caused cases 
of chronic toxoplasmosis without a tissue biopsy.  
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1.9 Aims and Objectives 
 
   In this study, we propose to measure the rates at which New Zealand’s most 
commonly consumed meats are contaminated with infectious T. gondii cysts 
through PCR analysis of meat samples taken at random from Hamilton meat 
outlets. If possible we will also attempt to genotype any T. gondii detected using 
PCR primer sets targeting polymorphic regions of the T. gondii genome. 
   The main aim of the research undertaken in this thesis was to develop a PCR 
assay to detect Toxoplasma gondii in fresh New Zealand farmed meat samples. To 
complete these aims, the following five objectives were fulfilled: 
Development and optimisation of DNA extraction methods for 
tachyzoite DNA from within a live T. gondii vaccine solution; 
oocyst DNA from within cat faecal samples; and  
bradyzoite DNA from within various types of animal muscle tissue. 
Development of reliable PCR assays for the detection of T. gondii specific DNA 
sequences; 
Assessment the effectiveness of developed PCR assays using positive controls and 
feline faecal extracts; 
Application of optimised PCR assays to test for the presence of (highly infectious) 
T. gondii bradyzoite cysts within fresh meat available in supermarkets and 
butcheries in the Hamilton area; and 
To confirm the results of PCR assays by DNA sequencing and restriction enzyme 
digest analysis. 
 
 
  
    16 
Chapter Two 
Materials and Methods 
 
2.1 Preparation of materials and solutions: 
 
   All glassware and spatulas used in preparation of solutions and meat sampling 
were cleaned and disinfected with a Miele® Professional G7839 washer 
disinfector using Asepti® medical and dental (disodium trioxosilicate) dishwasher 
powder. Certified DNase, RNase, human DNA and PCR inhibitor free 
Multimax® centrifuge tubes and pipette tips used were all further sterilised with 
72hours at 80ᵒC (dry) heat. Certified DNase, RNase, human DNA and PCR 
inhibitor free Neptune 2mL conical base screw top tubes were used for all 
proteinase K meat and GITC faecal DNA extractions. Biospec® Glass and Zircon 
beads were used in all ‘beadbeater’ homogenisation after 72hours at 80ᵒC dry heat 
treatment. Product details for all supplies and reagents along with recipes for all 
solutions and used can be found in appendices A1. 
 
2.2 DNA extraction of THP-1 Toxovax™ live T. gondii vaccine 
 
   Aliquots of 1.5 mL of Toxovax™ were centrifuged at 16,000xg and the 
supernatant was removed. The resulting cellular pellet was suspended in 350µL 
SDS lysis solution and 10µL (60U/mL) proteinase K. This solution was then 
incubated at 55°C overnight. 
   Toxovax™ digests were combined with an equal volume of 5M LiCl (350µL), 
mixed and then added to 700µL chloroform and further mixed by vigorous 
shaking for 20s followed by 10 minutes on a mixing wheel. This mixture was then 
separated by centrifugation at 16,000G for 5 minutes. The supernatant was then 
removed using a fine tip dispensing pipette and combined with an equal volume 
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of IPA. The IPA/supernatant solution was then chilled at -16°C overnight to 
induce DNA precipitation. After centrifugation at 16,000xg the supernatant was 
removed and the remaining DNA pellet washed with 1mL 70% ethanol then dried 
and suspended in 1X TE buffer. The DNA was then quantified by analysis at 
260/280nm and 230/260nm using a Thermo Scientific Nano2000 
spectrophotometer. 
2.3 Faecal DNA Extraction 
2.3.1 Procurement of Faecal Samples 
   Faecal samples were obtained in from various sources: Most samples were 
provided from veterinary clinics from around the Waikato following a cold-
calling campaign; the majority of these were from Raglan vets who deal with 
relatively large numbers of feral and stray cats. Other samples were brought in by 
friends and classmates from urban litterboxes and 4 samples were obtained from a 
freshly dug garden in a Hamilton suburb. 
2.3.2 GTIC – Charcoal extraction of faecal DNA 
   An effective faecal DNA extraction method was developed owing to the 
presence of inhibitory factors in faeces. Initial trials produced DNA pellets 
containing unknown ionic or protein inhibitors of Taq polymerase function when 
tested with bacterial specific 16S primers. Chelex treatment (see below) was 
incompletely successful in solving this problem. Treatment of DNA suspended in 
TE with 1% activated charcoal was also inconsistent. This GITC method 
consisted of using small quantities ~ (0.1 to 0.2 grams dependant on water 
content/viscosity) extracted from sample vials with sterile swab into a 1.7 mL 
screw top eppendorf tube (containing 350µL SDS lysis solution) and heated at 
95°C for 10 minutes. 600µL GTIC solution was then added and solids 
homogenised using the stick from a sterile swab followed by 10 minutes at 95°C 
and 900rpm agitation. Treatment with 1% activated charcoal was then carried out 
by addition of 60µL (10%) activated charcoal solution followed by mixing by 
vortex and 5 minutes rest. An equal volume of phenol chloroform was then added, 
mixed by vigorous shaking and 20min on a mixing wheel. The mixture was the 
centrifuged at 16,00G for ten minutes and the supernatant transferred to a 1.5mL 
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centrifuge tube using a fine tip dispensing pipette. The DNA was pelleted by 
adding an equal volume of IPA and centrifuged at 16,00xg for 15min. The pellet 
was then dissolved in 100µL SDS lysis solution followed by the addition of 
100µL 5M NaCl and 80µL 10% CTAB were added and incubated at 65°C for 
10min (at 900rpm). After cooling an equal volume of chloroform was added and 
shaken vigorously by hand for 40s or until any wax-like deposits had dissolved.     
The solutions were then put on a mixing wheel for 10min. After centrifugation at 
16,000G for 10 minutes the aqueous phase was removed into a second 1.5mL 
centrifuge tube using a fine tip dispensing pipette to which an equal volume of 
IPA was added. The solution was then cooled to -16ºC overnight to induce the 
precipitation of DNA. The following morning a DNA pellet was produced by 
centrifugation and washed with 70% ethanol (as in section 3.1). The final DNA 
pellet was then dissolved in 1XTE in preparation for gel purification. 
   Ten microliters of loading buffer was added to each 50µL faecal DNA sample 
which was then divided into two thin 12 wells in a 1% agarose-superbuffer gel 
containing 3µL of ethidium bromide (10mg/mL) and electrophoresed for 10 
minutes at 200V and 500mA. Genomic high molecular weight DNA bands were 
then visualised using blue light and cut from the gel using the thin end of cut 
200µL sterilised micropipette tips and stored in weighed 1.5mL centrifuge tubes. 
DNA was then purified from the gel plugs using a DNA pure© gel extraction kit 
(see materials). Two microliters of cresol red was added to the gel extraction 
buffer to ensure pH<7.5. 
 
2.4 Extraction of DNA from Meat Samples 
 
2.4.1 Procuring meat samples 
   Fresh mince was purchased from butchers shops and supermarkets in the central 
Hamilton and east Hamilton areas. From each meat tray/bag samples were taken 
in a randomised fashion to make up two 20 gram aliquots of each mince type to be 
stored at -16°C in 50mL raliegh tubes. 
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2.4.2  Proteinase K digestion (hydroxylation) 
  Three 0.1 to 0.17 gram samples taken at random and added to 1.5mL screw top 
eppendorf tubes containing ~ 0.1mL of 0.5mm zircon beads and 6 or 7 2.5mm 
glass beads. Seven hundred microliters of SDS lysis solution was added to each 
tube and homogenisation using an eppendorf minibead beater for one minute. 
Each tube was then spun down for 30 seconds to reduce foam content and 25µL 
(60 units/mL) proteinase K added. Each digest was then incubated in an 
eppendorf thermomixer for one hour at 55°C (at 750 rpm) followed by a further 
2.5 hours at 65°C (at 750rpm). For chicken mince and fish negative controls (Dr S 
Bird, UoW) a significantly greater DNA yield was achieved when incubated 
overnight at 65°C. To stop enzyme activity each tube was heated to 95°C for 15 
minutes. 
  To each cooled digest-lysis solution an equal amount of 50/50 phenol 
chloroform solution was added and mixed vigorously for 20s by hand before a 
further 20min mixing on a mixing wheel. After mixing the aqueous and non-polar 
phases were separated by centrifugation for 10 minutes at 16,000G. Six hundred 
microliters of the supernatant aqueous phase was then removed to a 1.5mL 
centrifuge tube using a fine tip pasture/dispensing pipette. 100µL 5M NaCl and 
80µL 10% CTAB were added and incubated 15min at 55°C. After cooling an 
equal volume of chloroform was added and shaken vigorously by hand for 40 
seconds or until any wax like deposits were dissolved. The solutions were then put 
on the mixing wheel for at least 10 minutes. The aqueous supernatant phase was 
again separated into a separate 1.5mL centrifuge tube and an equal volume IPA 
added. Tubes were then cooled to -15°C overnight to induce DNA precipitation. 
The chilled DNA precipitate was centrifuged at 16,000G for 15 minutes to form a 
pallet and the supernatant discarded. The pellets were then washed with 1mL 70% 
ethanol. The supernatant was then removed using a fine tip dispensing pipette and 
the pellets allowed to dry (1Hr in fume hood). The pellets were then suspended in 
50µL TE buffer for storage prior to purification by gel electrophoresis. 
   To separate large molecular weight DNA and remove potentially inhibitory 
contaminants total DNA extract (suspended in 1X TE buffer) was mixed 
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thoroughly with 6X GelRed™ DNA stain and loaded into ‘thick 10’ wells before 
being electrophoresed through a 1% agarose TAE gel for 40 minutes at 90V and 
500mA. The resulting dispersion of nucleic acids through the agarose gel left 
large high weight DNA fragments along the edge of the wells (see Figure 2.1 
below). 
  
 
Figure 2.1 Beef5 Purification of high molecular weight DNA by gel 
electrophoresis. High molecular weight DNA can be observed as the dark stripes 
close to the edge of each well. Approximate cut area is indicated by the black 
rings. 
   The high molecular weight DNA was the cut from the gel using the wide end of 
sterilised (cut) 200µL micropipette tips and stored in pre-weighed 1.5mL 
centrifuge tubes and purified using the Geneaid quickclean II™ gel extraction kit. 
Best results were obtained when 25% (of volume) IPA was added to the binding 
buffer/gel mixture prior to being passed through the spin column and higher yields 
were obtained when the elution buffer was allowed to stand in the spin column for 
several minutes during the final (elution) step. 
2.4.3  Poly ethylene glycol precipitation of high molecular weight DNA 
   Unpurified (total) DNA in 1X TE (140µL at ~ 300ng/µL) was combined with 
1/4th volume 20% PEG solution (+2.5M NaCl) mixed thoroughly and allowed to 
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sit at room temperature for 15 minutes. Solution was then centrifuged at 
13,000rpm. The supernatant was then removed and the pellet washed with 1mL 
100% ethanol, centrifuged and washed again with 1mL 70% ethanol. After drying 
the resulting purified DNA was solubilised in (15µL) TE buffer (giving a 
nanodrop reading of 17.8ng/µL). 
2.4.4  Pepsin / proteinase k digestion  
   A 1g pork mince (Pork1) was combined with 5ml (0.85%) NaCl and digested by 
addition of an equal pepsin-HCl solution (5mL0.1M HCl, 50mg NaCl, 0.7mg 
Pepsin) and incubated at 37°C for 1 hour. The solution was then centrifuged for 
10 minutes at 1800g and the supernatant was removed using a dispensing pipette. 
The pallet suspended in 1mL SDS lysis solution and 50µL (60U/mL) proteinase K. 
and incubated overnight at 37°C. The digest was then transferred to a 2mL 
minicentrifuge tube and incubated in an eppendorf thermomixer for 1hour at 80°C 
with 750rpm agitation. The solution was then divided into two equal volumes and 
incubated at 95°C for a further 10 minutes with 850rpm agitation. DNA was 
extracted and purified using the phenol chloroform method (as in section 2.22 and 
2.23). 
2.4.5  Chelex treatment 
   DNA extracts suspended in TE buffer were diluted 1:5 (DNA + TE : Chelex 
solution) then mixed thoroughly and rested at room temperature. The resulting 
solutions were then trialled as templates for 16Sr DNA primer PCR reactions. 
 
2.5 PCR Protocols 
 
   All meat and Toxovax™ DNA PCR reactions were carried out with 
approximately 2ng template DNA /µL reaction mixture. Faecal DNA extract 
concentrations meant significantly lower template DNA concentrations (as low as 
0.4ng/µL in some cases). Forward and reverse primer concentrations of 
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0.2pmol/µL reaction mixture was used in all cases. See materials for PCR reaction 
mixture details. 
 
 
Table 2.1 Thermocycler protocols. Times and temperatures for initial melt, 
touchdown and standard PCR cycles and final extension. 
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2.6 Sequencing and sequence analysis 
 
   One microlitre of alkaline phosphate and 1µL of exonucleaseI was mixed with 
30µL of PCR product and incubated at 37ᵒC for 15 minutes. The solution was 
then heated at 55ᵒC for 15 minutes to inactivate the enzymes and then sent for 
DNA sequencing. 
   DNA sequences were resolved using a 3130XL Genetic Analyzer System fitted 
with 50 cm capillary arrays (Life Technologies Corporation) loaded with 
POP-7 polyacrylamide matrix (Life Technologies Corporation).  DNA templates 
were prepared using Big Dye v3.1 terminator chemistry (Life Technologies 
Corporation). 
   Sequence analysis was carried out using Biomatters Genious© R7 software 
package. 
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Chapter Three 
Results 
 
3.1 Positive and negative controls: 
 
   Positive and negative controls were developed to assess the effectiveness of the 
primer sets shown in Table 3.1. The positive control was effective in almost all 
cases but non-specific amplification was a factor in the negative control 
developed. 
 
Table 3.1 Primer target regions, expected product sizes, sequences and 
references. 
   Table 3.1 shows the primers selected from literature and generated using NCBI 
blast which were selected for this study based upon the criteria of sensitivity, 
specificity and previous success’s. 
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3.1.1. Positive controls: 
   DNA was extracted and purified from Toxovax™, the MSD Animal Health® 
live toxoplasmosis vaccine for sheep (see Figure 3.1) using the proteinase K 
digestion and phenol/chloroform extraction (see methods). A DNA extract was 
also purified from Toxovax™ which had been grown in THP-1 (human 
monocytic) cell culture. These extraction results are summarised in Table 3.1 
 
 
 
 
 
 
 
 
 
Figure 3.1 Toxovax™ under 1000X magnification. No stain. Viewed with a 
Zeiss Axiostar™ plus transmitted light microscope fitted with a Canon Coolpix™ 
4500 digital camera. Live tachyzoites can be seen indicated by arrows.  
 
 
Table 3.2 Nanodrop concentration readings of purified Toxovax™ (MSD 
animal health®) DNA extracts. 
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   Toxovax™ THP-1 DNA extract was diluted to 100ng/µL in 1X TE buffer as a 
positive control for PCR reactions. This control was first used to test the 
specificity (and functionality) of sixteen primer sets and combinations of primer 
sets (eg: SAG449F/ P30R) that targeted the same region. 
   PCR reactions were all carried out using 100ng template (Toxovax™ DNA 
extract) and 2µL 5pM forward and reverse primers. The thermocyler protocol 63 
(see methods), a ten cycle touchdown to 56°C followed by 35 standard cycles was 
used to amplify the PCR products visible in Figures 3.2 and 3.3. 
    
 
Figure 3.1.2 Toxovax™ THP1 positive control primer test 1. Lane1: Solis 
Biodyne 100bp ladder. Lane2: API. Lane 3:GRA6. Lane 4:L358. Lane5:NN1/2. 
Lane6:SAG2. Lane7:SAG449. Lane8:449F/P30R. Negatives run in top lanes. Gel: 
1% agarose in SB + 3µL Ethidium bromide (10mg/mL) 
    27 
 
Figure 3.1.3 Toxovax™ THP1 positive control primer test 2. Lane1: Solis 
Biodyne™ 100bp DNA ladder. Lane2:AF. Lane3:API184. Lane4:B1. Lane5:ITS. 
Lane6:P30. Lane7:SAG3. Lane8:TGR1E. Lane9:UPRT. Negatives run in top 
lanes. Gel: 1% agarose in SB + 3µL Ethidium bromide (10mg/mL) 
 
   All reactions gave product bands of the expected size with the exception of 
SAG2 and B22. It was discovered late in the study that owing to a misprint in 
(Alfonso et al., 2013) in which resulted in a primer set targeting a much larger 
(1776bp) region of B1 than intended had been ordered. The tabulated primer 
sequences (Alfonso et al., 2013) indicate a 190bp PCR product should be 
produced and reference Bretagne et.al. 1993 (Bretagne, Costa, Vidaud, Van 
Nhieu, & Feith, 1993) however only one of these primers is a match for primer set 
indicated in the original 1993 study. The reason for lack of SAG2 amplification 
was unknown but may be a reflection of the attenuation of the Toxovax©  genome 
or scientific error. 
   The primer sets targeting, SAG3 and GRA6 and SAG1nested set of outer 
primers: SAG449F/P30R and inner primers:SAG1F/SAG449R were used to test 
for the presence of T. gondii within faecal samples owing to the high product 
concentration achieved in the initial tests against the Toxovax™ DNA extract and 
the potential for polymorphism between T. gondii strains at these loci/targets. 
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   Sequencing of SAG1(nest) PCR product from Toxovax™ template gave the 
following BLAST hits: 
SAG1F: 
Toxoplasma gondii strain RMS-1994-LEF major surface antigen (SAG1) gene, 
complete cds. Evalue = 1.30e-140. Grade =100%. Hit start:280, Hit end: 554. 
P30R: 
Toxoplasma gondii strain P-Br SAG1 protein (SAG1) gene, complete cds.          
Evalue=0, Grade = 99.9. Hit start:470, Hit end:57. 
(See Appendix 2 for chromatograms) 
 
3.1.2. Negative controls: 
   Negative controls were generated by the extraction of high molecular weight 
DNA from three fish species as cold blooded animals are not known to be hosts 
for T. gondii (Dubey, 2008). The scales, fins and digestive tract were removed 
from each specimen and the remaining tissues were homogenised for proteinase K 
/ phenol-chloroform DNA extraction followed by gel purification of high 
molecular mass DNA fragments (See methods section 2.3) 
 
Table 3.3. Negative control DNA extraction results. Shows the gel purified 
nucleic acid yield resulting from each fish meat digest trialled.  
   The first (misc.) fish sample was a freshwater fish of unknown species sourced 
from a small lake in the Waikato area by the Waikato universities Aquatic 
Research Centre This specimen was in poor condition and provided only a small 
amount of gel purified DNA, which was later found to test positive for T. gondii 
SAG1 DNA when tested with nested PCR indicating probable contamination 
within these DNA extracts or the primer sets used in these reactions.  
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   The second fish sample (shark) came from the fin of a shark caught in the 
Kaipara Harbour (cc. Dr Stevin Bird) and stored frozen at low temperature. 
Although this sample gave a greater DNA yield it was also found to test positive 
for T. gondii SAG1 DNA when tested with nested PCR. 
   The third fish DNA extract was obtained from a fresh Zebrafish harvested from 
the University of Waikato C.2.03 (molecular genetics lab) Zebrafish tank. This 
specimen was humanely euthanized using an anaesthetic solution. The gel 
purified high molecular weight DNA was found to test negative for T. gondii 
specific sequences using SAG1F/SAG449R (see figure 3.4), SAG 3 (see figure 
3.5) and the NN1/2 outer and ITS inner nested primer sets. GRA6 primers gave a 
>500bp non-specific PCR product (see figure 3.6) which sequencing and BLAST 
analysis showed was clearly a Zebrafish specific sequence with a significant size 
difference (500bp vs an expected 343bp) 
 
 
 
 
 
 
 
Figure 3.1.4 Toxovax™ THP-1 positive control and Zebrafish negative 
control amplified using SAG1F/SAG449 primers. Lane 1 Toxovax™ THP-1 
positive control, Lane 2: Empty, Lane 3: Zebrafish, Lane 4: Blank (2µL 1XTE), 
Lane 5: Solis Biodyne™ 100bp DNA ladder. Visualised on a 1% agarose SB gel 
containing 3µL Ethidium bromide (10mg/mL) 
  
  1              2              3               4               5 
300bp 
500bp 
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Figure 3.1.5 Toxovax™ THP-1 positive control and Zebrafish negative 
control amplified using SAG3 primers. Lane 1: Toxovax™ positive control, 
Lane 2: CatV, Lane 3: CatT, Lane 4:CatR, Lane 5: Cat P, Lane 6: Zebrafish. Lane 
7: Solis Biodyne™ 100bp DNA ladder. Visualised on a 1% agarose SB gel 
containing 3µL Ethidium bromide (10mg/mL) 
 
 
 
 
 
 
Figure 3.1.6 Non specific product resulting from Zebrafish DNA extract 
amplified using GRA6 primers. Lane 1: Toxovax™ positive control, Lane 2: 
Empty, Lane 3: Cat T, Lane 4: Cat J, Lane 5: Non specific Zebrafish product, 
Lane 6 Solis Biodyne™ 100bp DNA ladder. Visualised on a 1% agarose SB gel 
containing 3µL Ethidium bromide (10mg/mL) 
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3.1.3. Summary of results for positive and negative controls 
 
 
Table 3.4 Summary of PCR results for positive and negative controls tested 
against various primer sets. Y= Product band of expected size observed. N= No 
product observed. NS= Product or products of incorrect size observed. (seq) 
indicates sequencing was carried out, see appendix for data. (cont.) indicates 
contamination of reaction. 
 
3.2 Faecal DNA extraction and PCR results     
A reliable extraction and purification technique was developed using GITC 
homogenisation followed by phenol chloroform extraction and gel purification.  
This overcame early extraction methods that proved unreliable at removing Taq 
polymerase inhibitory contaminants. Table 3.21 shows nucleic acid concentrations 
retrieved from all faecal samples. 260/280(nm) measurements close to 2.00 
indicates a high percentage of DNA. 
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3.2.1  PCR analysis of feline faecal DNA extracts 
   To test for the presence of Taq polymerase inhibitory contaminants within the 
faecal DNA extracts, PCR reactions were attempted using recombinant 16Sr DNA 
bacterial specific primers to control for false negatives. If inhibitory contaminants 
are present no PCR product will be produced. A band of 220bp would indicate a 
positive amplification and hence a lack of inhibitory contaminants. A negative 
control, containing no extracted DNA but containing bacterial DNA from the 
recombinant manufacturing process should always result in a 220bp PCR product. 
   Initial results showed amplification from some DNA samples extracted via 
GITC homogenisation followed by phenol chloroform DNA extraction. However, 
results were inconsistent (see figures 3.2.1, 3.2.2 and 3.2.3). 
 
 
 
 
 
 
Figure 3.2.1 16Sr DNA primer amplification of unpurified faecal extracts. 
Lane 1: Invitrogen™ kb+ DNA ladder. Lane 2: 16Sr positive control 
amplification. Lane 3: Cat B, Lane 4: Cat A. Visualised on a 2% agarose TAE gel 
containing 2µL Ethidium bromide (10mg/mL) 
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Table 3.5 Faecal DNA extraction results. All faecal DNA extracts shown. CC= 
activated charcoal treatment, PEG= polyethylene glycol precipitation of high 
molecular weight DNA, Column= purified using DNA pure™ DNA purification 
kits, Gel= purified by gel electrophoresis and extraction from gel using DNA 
pure™ gel extraction kits. 
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Figure 3.2.1 16Sr DNA primer amplification of unpurified faecal extracts. 
Lane 1: Invitrogen™ kb+ DNA ladder. Lane 2: 16Sr positive control 
amplification. Lane 3: Cat B, Lane 4: Cat A. Visualised on a 2% agarose TAE gel 
containing 2µL Ethidium bromide (10mg/mL) 
 
 
 
 
 
 
 
 
Figure 3.2.2 16Sr DNA primer amplification of faecal extracts. Lane 1: 16Sr 
positive control amplification. Lane 2: Cat D(unpurified), Lane 3: Negative 
control. Lane 4: Invitrogen™ kb+ DNA ladder. Visualised on a 2% agarose TAE 
gel containing 2µL Ethidium bromide (10mg/mL) 
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Figure 3.2.3 16Sr DNA primer amplification of faecal extracts. Lane 1: 
CatG(unpurified). Lane 2: Cat F(unpurified). Lane 3: Cat E(unpurified), Lane 4: 
16Sr control amplification. Lane 5: Invitrogen™ kb+ DNA ladder.  Visualised on 
a 2% agarose TAE gel containing 2µL Ethidium bromide (10mg/mL) 
 
   In an attempt to remove inhibitory ionic components, DNA extracts were treated 
with 5% (200 to 400) mesh chelex solution. This resulted in amplification in some 
of the previously inhibitory DNA samples (Cat E) but did not reliably remove all 
inhibitory contaminants (see figure 3.2.4 and 3.2.5 below).  
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Figure 3.2.4 16Sr DNA primer amplification of faecal DNA extracts. Lane 1: 
Cat H(chelex). Lane 2: Cat F(chelex 1). Lane 3: Cat E(chelex 1), Lane 4: 16Sr 
control amplification. Lane 5: Invitrogen™ kb+ DNA ladder.  Visualised on a 2% 
agarose TAE gel containing 2µL Ethidium bromide (10mg/mL) 
 
 
 
 
 
 
 
Figure 3.2.5 16Sr DNA primer amplification of faecal DNA extracts.  Lane 1: 
Cat J(unpurified). Lane 2: Cat I(unpurified). Lane 3: Cat F(chelex 2), Lane 4: 
16Sr control amplification. Lane 5: Invitrogen™ kb+ DNA ladder. Visualised on 
a 1% agarose SB gel containing 2µL Ethidium bromide (10mg/mL). 
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   The second method trialled in the attempt to eliminate inhibitory components 
was activated charcoal treatment (to remove organic contaminants). This method 
did not appear to be successful (see figures 3.2.7 and 3.2.8 below). These samples 
were sourced from Anexa animal health in Raglan and had been refrigerated, in 
some cases, for several months. 
 
 
 
 
 
 
 
 
Figure 3.2.6 Attempted amplification of activated charcoal treated faecal 
DNA extracts. Lane 1: Cat N, Lane 2: Cat P, Lane 3: Cat Q, Lane 4: Cat R, Lane 
5: Cat T, Lane 6: Cat U, Lane 6: 16Sr control amplification. Lane 7: Invitrogen™ 
kb+ DNA ladder. Visualised on a 1% agarose SB gel containing 2µL Ethidium 
bromide (10mg/mL) 
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Figure 3.2.7 Lack of visible PCR products from both untreated and charcoal 
treated DNA extracts. Lane 1: CatV (charcoal treated), Lane 2: Cat V 
(Untreated), Lane 3: Cat P (charcoal treated), Lane 4: Cat P (Untreated). Lane 5: 
16Sr control amplification, Lane 6: Invitrogen™ kb+ DNA ladder 
 
   When both chelex and activated charcoal treatment gave inconsistent results, gel 
purification was trialled. DNA extracts were elecrophosesed through a 1% agarose 
SB gel containing 2µL ethidium bromide for 10 minutes at 200 volts and 500mA. 
The resulting bands were punched out and purified using DNA pure™ gel 
extraction ‘spin columns’. The resulting DNA was consistently amplifiable (see 
figures 3.2.9 and 3.2.10). 
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Figure 3.2.8 16Sr DNA primer amplification from gel purified faecal DNA 
extracts. Lane 1: Cat V (charcoal treated and gel purified). Lane 2: Cat P 
(charcoal treated and gel purified) Lane 3: 16Sr control amplification, Lane 4: 
Invitrogen™ kb+ DNA ladder. Visualised on a 1% agarose SB gel containing 3µL 
Ethidium bromide. 
 
 
 
 
 
 
 
Figure 3.2.9 16Sr DNA primer amplification from gel purified faecal DNA 
extracts.  Lane 1: Cat K(charcoal and gel purified). Lane 3: Cat L(charcoal and 
gel purified), Lane 4: 16Sr control amplification. Lane 5: Invitrogen™ kb+ DNA 
ladder. Visualised on a 1% agarose SB gel containing 2µL Ethidium bromide 
(10mg/mL) 
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   Low DNA yield presented some problems in that, at low concentrations 
(<10ng/µL, Table 3.21) the PCR reaction mixtures had to be diluted by up to 10% 
in some cases with DNA template solution. Amplification of T. gondii specific 
PCR products was achieved using three primer sets targeting regions thought to be 
polymorphic and useful as genotyping markers however inconsistencies were 
observed. 
   Specimens from ‘at risk’ felines, typically young feral cats or old unhealthy cats 
gave a particularly high rate of T. gondii positive results using SAG3 and GRA6 
primer sets. All results for samples known to be from young domestic cats were T. 
gondii negative. There are likely several factors behind these observations ie: diet, 
hunting and feline leukemia virus (see discussion). 
   SAG2 was targeted in a preliminary trial giving a single product band close to 
the expected size of 334bp in one case and multiple products in one case. 
Surprisingly, amplification was achieved using these primers which had 
previously failed to produce a product when trialled with Toxovax™ DNA 
extract.  
   Single copy SAG1, SAG3 and GRA6 targets were reliable T. gondii specific 
targets. A broader sample set was covered with the latter two targets. Results were 
contradictory in three of the nine cases where both SAG3 and GRA6 targets were 
amplified from the same DNA extracts; the reason for this is unknown but is 
likely due to scientific error. 
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3.2.2  SAG3 amplification: 
 
 
 
 
 
 
 
Figure 3.2.10 SAG3 amplification of charcoal treated and gel purified faecal 
DNA extracts and positive control. Lane 1: Solis Biodyne™ 100bp DNA ladder, 
Lane 2: Toxovax™ positive control, Lane 3: empty, Lane 4: Cat V (charcoal and 
gel purified), Lane 5: Cat P(charcoal and gel purified), Lane 6: Negative control, 
Lane 7: Solis Biodyne™ 100bp DNA ladder. Visualised on a 1% agarose SB gel 
containing 2µL Ethidium bromide (10mg/mL) 
 
   Figures 3.2.12 and 3.2.13 (below) demonstrate the potential inconsistencies 
between different primer sets (PCR targets). Cat R DNA extract gave a result 
consistent with the presence of T. gondii DNA when amplified using SAG3 
primers however no product was observed when the same sample was amplified 
using SAG449F/P30R (SAG1 locus) primers. Cat T DNA was not amplified due 
to the failure of a PCR tube but was successful in a later attempt. 
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Figure 3.2.11 SAG3 amplification of charcoal + gel purified faecal extracts 
with positive and negative controls. Lane 1: Toxovax™ positive control, Lane 2: 
Cat V, Lane 3: Cat T, Lane 4: Cat R, Lane 5: Cat P, Lane 6: Zebrafish negative 
control. Lane 7: Invitrogen™ Kb+ DNA ladder. Bands below 100 bp are primer 
dimers. Visualised on a 1% agarose SB gel containing 2µL Ethidium bromide 
(10mg/mL) 
 
 
 
 
 
 
 
 
Figure 3.2.12 SAG449F/P30R amplification of four faecal extracts . Lane 1: 
empty, Lane 2: Toxovax™ positive control, Lane 3: Cat V, Lane 4: Cat T 
(evaporated reaction mixture), Lane 5:Cat R, Lane 6: Cat P, Lane 7: Zebrafish 
negative control, Lane 8: Invitrogen™ Kb+ DNA ladder. Visualised on a 1% 
agarose SB gel containing 2µL Ethidium bromide (10mg/mL). 
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Figure 3.2.13 SAG3 amplification of faecal DNA extracts. Lane 1: Cat S. Lane 
2: Cat L, Lane 3: Cat E Lane 4: Cat F, Lane 5: Cat G, Lane 6 Cat I, Lane 7: Cat J, 
Lane 8: Cat K, Lane 9: Cat L, Lane 10: Cat S. Visualised on a 1% agarose SB gel 
containing 3µL Ethidium bromide (10mg/mL). 
 
   Figure 3.2.14 demonstrates the high rate of results indicating the presence of 
T. gondii in faecal samples from feral cats in the Raglan area. Nine out of the ten 
samples obtained (a single consignment of samples) tested positive for the 
presence of T. gondii SAG3 DNA. 
   SAG1 amplification was achievable using primer sets SAG449F/P30R and 
SAG1F/SAG449R (see Figure 3.2.13). Positive results matched those for SAG3 
primers in 3 of 5 cases and gave multiple products in a fourth. SAG3 and GRA6 
targets were preferable overall because of higher product concentrations and 
greater probability of polymorphisms and were used in larger numbers trials. PCR 
results are summarised in Table 3.2 below. 
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3.2.3  GRA6 Amplification 
   GRA6 proved to be a reliable PCR target for faecal DNA extracts. Where 
amplification occurred, PCR products were specific giving product bands of the 
expected (343bp) size. 
 
 
 
 
 
 
Figure 3.2.14 GRA6 amplification of faecal DNA extracts. Lane 1: 100bp Solis 
biodyne™ DNA ladder, Lane 2: Zebrafish mispriming product, Lane 3: CatJ, 
Lane 4 CatT, Lane 5: empty,  Lane 6: Positive (Toxovax™) control. Amplified 
using protocol 67. Visualised using a 1% agarose SB gel containing 3µL ethidium 
bromide (10mg/mL). 
 
 
 
 
 
 
Figure 3.2.15 GRA6 amplification of faecal DNA extracts. Lane 1: Cat I, Lane 
2: Cat H, Lane 3: Cat G, Lane 4: Cat F, Lane 5: Cat E, Lane 6:Cat D, Lane 7: Cat 
C, Lane 8: Cat B, Lane 9: Zebrafish mispriming product, Lane 10: Solis 
Biodyne™ 100bp DNA ladder. Visualised on a 1% agarose SB gel containing 
2µL Ethidium bromide (10mg/mL). 
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Table 3.6 Amplification of PCR products from faecal DNA extracts. S= single 
product amplified. N= No product amplified. MP= multiple products. (seq) = 
sequencing was attempted (see appendix for detail).  
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3.2.4  Restriction digest of faecal GRA6 PCR products. 
   A restriction enzyme digest was used to confirm the identity of five GRA6 PCR 
products. The MseI cut pattern closely matches what one would expect for GRA6 
originating from the type II archetypal strain of T. gondii. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2.16 GRA6 PCR products from feline faecal samples. At top:Lane 1: 
Toxovax™ positive control, Lane 2: Cat I, Lane 3, Cat G, Lane 4 Cat F, Lane 5: 
Cat E, Lane 6: Cat D, Lane 7: Cat C, Lane 8: Cat B, Lane 9: Zebrafish mispriming 
product band, Lane 10: Solis Biodyne™ 100bp DNA ladder. At bottom: Lane 1: 
Toxovax™ positive control, Lane 2: Cat Q, Lane 3: Cat P, Lane 4: Cat N, Lane 5: 
Cat M, Lane 6: Cat L, Lane 7: Cat K, Lane 8: Cat J, Lane 9: Zebrafish mispriming 
product band, Lane 10: Solis Biodyne™ 100bp DNA ladder. Both images 
visualised using a 1% agarose SB gel containing 3µL ethidium bromide. 
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   Amplified GRA6 products were selected for digestion on the basis of product 
concentration and greatest possible sample source distribution. Following twenty 
four hours incubation, all samples including Toxovax™ had undergone the same 
cut pattern giving distinct banding at approximately 280bp (see Figure 3.4) as 
would be expected from GRA6 sequences homologous with type II 
toxoplasmosis. 
 
 
 
 
Figure 3.2.17 MseI restriction enzyme digest of GRA6 PCR products. Right to 
left: Lane 1: Solis Biodyne 100bp DNA ladder. Lane 2: CatC. Lane3: CatI. Lane 
4: CatG. Lane 5: CatL. Lane6: CatP. Lane 7: Toxovax™ positive control. 
Visualised on a 2% agarose TAE gel containing 2µL Ethidium bromide. 
 
   The high frequency at which T. gondii DNA was detected in feral feline faecal 
DNA extracts was unexpected given that felidae are thought to usually contract 
T. gondii at a young age when they will shed oocysts for a period of around two 
weeks following infection (J. Dubey, 2009) followed by a dormant period of up to 
6 years during which very little or no shedding is expected. Immunosuppressive 
events have been shown to result in re-shedding (Malmasi, Mosallanejad, 
Mohebali, Sharifian Fard, & Taheri, 2009). In addition, Malmasi et al., 2009 
demonstrated that rechallange by oral administration of T. gondii infected murine 
brain homogenate also resulted in re-shedding after 19 to 20 days. 
   Re-shedding may explain the high proportion of T. gondii positive results 
among faecal samples. All samples were obtained from veterinary clinics caring 
for either young, old or unhealthy cats, many of which were feral cats that were to 
be euthanized as part of a wildlife protection programme in the Raglan area. 
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These feral cats would be active hunters. By eating birds, mice and rat, these cats 
would be at significantly greater risk of toxoplasmosis infection and reinfection 
(rechallange) through bradyzoite consumption. Another contributing factor is that 
the dietary and physical stresses of a hunting and scavenging feral lifestyle could 
be great enough to compromise the immune system in host cats leading to 
‘flourishing’ of existing infections and consequently oocyst shedding. Domestic 
cats on the other hand are generally healthier and their diets composed of 
processed foods that would not contain active oocysts (ie: cat biscuits and canned 
food). 
   The feline leukemia virus (FeLV) has become widespread throughout global 
Felidae populations. This virus has a significant impact upon its host’s ability to 
respond to pathogenic challenge (such as toxoplasmosis) effectively. Due to its 
similarity in this respect FeLV is often referred to as cat AIDS. Domestic cats are 
now mostly immunised against this virus (especially younger cats) however the 
virus still infects a significant portion of the feral cat population. This 
compromised immune response of these infected cats is likely directly linked to 
reshedding of T. gondii oocysts as they consume prey animals with chronic 
(bradyzoite) toxoplasmosis infection. 
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3.2.5  SAG3 Sequencing results 
   Figures 3.2.19 and 3.2.20 show that the DNA extracted from Toxovax™ 
vaccine which was subsequently amplified using the SAG3 primers and 
sequenced was indeed T. gondii.   
 
Figure 3.2.18 Chromatogram of Toxovax™ positive control amplified DNA 
using the SAG3F primer. This sequence was analysed using NCBI nr Megablast and 
aligned with the top hit Genbank Accession number L21720 (T. gondii surface antigen 43 
(SAG3) mRNA from position 1303-1449) with an E value of 8.81e-70 and a Grade score 
of 100%. 
 
Figure 3.2.19 Chromatogram of Toxovax™ positive control amplified DNA 
using the SAG3R primer. This sequence was analysed using NCBI nr Megablast and 
aligned with the top hit Genbank Accession number AF340227 (T. gondii surface antigen 
43 (SAG3) mRNA from position 1078-916) with an E value of 81.27e-78 and a Grade 
score of 100%. 
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   The Expect (E) value represents the number of hits one can "expect" to see by 
chance when searching a database of a particular size. The grade score is a 
weighted score for the hit comprise of the E-value, the pairwise identity and the 
coverage. 
   Three PCR products (from catR, CatT and catV DNA extracts) amplified with 
SAG3 primers were confirmed as T. gondii SAG3 using sequencing and nr 
megablast analysis.  The overall sequencing quality was high as demonstrated by 
clear distinct nucleotide peaks. 
 
 
Figure 3.2.20 Chromatogram of CatR amplified DNA using the SAG3F 
primer. This sequence was analysed using NCBI nr Megablast and aligned with the top 
hit Genbank Accession number L21720 (T. gondii surface antigen 43 (SAG3) mRNA 
from position 1306-1454) with an E value of 6.93e-71and a Grade score of 100%. 
 
Figure 3.2.21 Chromatogram of CatR amplified DNA using the SAG3R 
primer. This sequence was analysed using NCBI nr Megablast and aligned with the top 
hit Genbank Accession number AF340227 (T. gondii surface antigen 43 (SAG3) mRNA). 
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Figure 3.2.22 Chromatogram of CatT amplified DNA using the SAG3F 
primer. This sequence was analysed using NCBI nr Megablast and aligned with the top 
hit Genbank Accession number L21720 (T. gondii surface antigen 43 (SAG3) mRNA 
from position 1252-1467) with an E value of 6.20e-108 and a Grade score of 100%. 
 
 
 
Figure 3.2.23 Chromatogram of CatT amplified DNA using the SAG3R 
primer. This sequence was analysed using NCBI nr Megablast and aligned with the top 
hit Genbank Accession number AF340227 (T. gondii surface antigen 43 (SAG3) mRNA 
from position 1060-871) with an E value of 1.51e-93 and a Grade score of 100%. 
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Figure 3.2.24 Chromatogram of CatV amplified DNA using the SAG3F 
primer. This sequence was analysed using NCBI nr Megablast and aligned with the top 
hit Genbank Accession number L21720 (T. gondii surface antigen 43 (SAG3) mRNA 
from position 1365-1464) with an E value of 2.29e-65 and a Grade score of 100%. 
 
 
Figure 3.2.25 Chromatogram of CatV amplified DNA using the SAG3R 
primer. This sequence was analysed using NCBI nr Megablast and aligned with the top 
hit Genbank Accession number AF340227 (T. gondii surface antigen 43 (SAG3) mRNA 
from position 1102-992) with an E value of 6.31e-50 and a Grade score of 100%. 
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3.3  Meat DNA extraction  
 
DNA was extracted from 25 samples of fresh mince from beef, lamb, pork and chicken. 
Table 3.3 shows that DNA was extracted from meat that was purchased from a single 
supermarket (Meat 1). For example, beef1(complete) refers to a sample of beef that was 
homogenised, and digested with proteinase K and purified using phenol:chloroform and 
the DNA concentration was 1173 ng/uL. The nanodrop reading suggests that the DNA is 
of good quality due to a absorbance reading of 1.98 at 260/280. Due to issues with PCR 
(Section 3.3), this DNA sample was later gel purified (Beef1 Gel) and as a result, the 
concentration was reduced to 173.4 ng/uL. In summary, nucleic acid concentration from 
the four  extraction methods ranged from 3.3 ng/uL to 4971.6 ng/uL (Table 1 and 
Appendix 3) 
 
 
Table 3.7 Nanodrop of extracted DNA of meat sourced from supermarket 1.  
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3.4.  PCR analysis of purified meat DNA extracts. 
  
3.4.1  Repeat region PCR targets: 
   Initial attempts were made to amplify T. gondii specific PCR targets using high 
sensitivity PCR primers targeting repeat regions within the T. gondii genome. 
Although these attempts using these primers with DNA extracted from four meat 
varieties gave product amplification, results were poor in most cases, ie: weak 
amplification levels with often multiple product bands indicated mispriming due 
to non-specific primers or potentially multiple infecting strains polymorphic at 
these target sites. (See figure 3.4.1 below.) 
 
 
 
 
 
 
 
 
 
 
Figure 3.4.1. AFRE, B22/23 and TGR1R repeat region amplification from 
purified Meat1 DNA. Lanes 1-4 B22/23 amplification of: Lane 1: Pork1, Lane 2: 
Lamb1, Lane 3: Chicken 1, Lane 4, Beef1. Lane 5: Genescript 100bp DNA 
ladder. Lane 6: B22/23 negative. Lane 7 to 11 AFRE amplification of: Lane 7: 
Pork1, Lane 8: Lamb1, Lane 9: Beef1. Lane 10: Chicken 1. Lane 11: Negative. 
Lanes 12 to 15: TGR1E amplification, Lane12:Pork1, Lane 13:Lamb1 Lane 14: 
Beef1, Lane 16: TGR1E negative. Visualised on a 1% agarose TAE gel 
containing 2µl Ethidium bromide (10mg/mL).  
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Gel purification of complete DNA extracts gave improved results (see Figure 
3.4.2), however chicken DNA had seemed to have been degraded to a state where 
only a negligible amount of high molecular weight DNA could be retrieved which 
was at a concentration that was not practical for PCR reactions. 
 
 
 
 
 
 
 
 
Figure 3.4.2. AFRE, B22/23 and TGR1R repeat region amplification from 
purified Meat1 DNA. Top right: B22/23 primer dimer from negative. Lanes 1-3 
B22/23 amplification of: Lane 1: Pork1, Lane 2: Lamb1, Lane 3: Beef1. Lanes 4-
7: AFRE amplification of: Lane 4: Pork1, Lane 5: Lamb1, Lane 6: Beef1, Lane 7: 
Negative. Lanes 8-11: TGR1E amplification of: Lane 8: Pork1, Lane 9: Lamb1, 
Lane 10: Beef 1. Lane 11 TGR1E negative. Lane 12 Genescript™ 100bp DNA 
ladder. Visualised on a 1% agarose TAE gel containing 2µL Ethidium bromide 
(10mg/mL). 
 
3.4.2  Single copy PCR targets: 
   Gel purification of Meat1 DNA extracts along with modified thermocycler 
protocols (to suit smaller PCR products) gave improved results for single copy 
P30 and SAG1 PCR targets. The difference can be observed in Figure 3.4.3 
(unpurified) cf. Figures 3.4.4 and 3.4.5 (both gel purified). 
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Figure 3.4.3 P30 and SAG1 amplification of Meat1 DNA extracts.  Lanes 1-4 
SAG1 amplification of: Lane 1: Pork1, Lane2: Lamb1, Lane 3: Beef3, Lane 4: 
SAG1 negative, Lane 5-8: P30 amplification, Lane 5 Pork1, Lane 6: Lamb1, Lane 
7: Beef1. Lane 8: P30 negative control. Lane 9: Genescript™ 100bp DNA ladder. 
Visualised on a 1% agarose gel containing 2µL Ethidium bromide (10mg/mL). 
 
 
 
 
 
 
 
Figure 3.4.3 P30 and SAG1 amplification of Meat1 DNA extracts.  Lanes 1-4 
SAG1 amplification of: Lane 1: Pork1, Lane2: Lamb1, Lane 3: Beef3, Lane 4: 
SAG1 negative, Lane 5-8: P30 amplification, Lane 5 Pork1, Lane 6: Lamb1, Lane 
7: Beef1. Lane 8: P30 negative control. Lane 9: Genescript™ 100bp DNA ladder. 
Visualised on a 1% agarose gel containing 2µL Ethidium bromide (10mg/mL). 
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Figure 3.4.4 P30 and SAG1 amplification of Meat1 gel purified DNA. Lane 1-
4 SAG1 amplification: Lane 1: Pork1, Lane 2: Lamb, Lane 3: Beef1, Lane 4 
SAG1 negative control. Lanes 5-8 P30 amplification: Lane 5: Pork1, Lane 6: 
Lamb1, Lane 7, Beef1. Lane 8: Genescript™ 100bp DNA ladder. Visualised on a 
2% agarose TAE gel containing 2µL Ethidium bromide (10mg/mL). 
 
   In all but one occurrence (New Zealand farmed pork mince) T. gondii DNA 
could not be detected in meat DNA extracts using standard PCR protocols. This 
positive result was confirmed through sequencing (see appendix). An attempt was 
made to replicate this result using the same pork DNA extract (Pork1) along with 
Lamb1 and Beef1 DNA. The original positive result could not be replicated (see 
sequence results in appendix). No further T. gondii specific DNA sequence was 
amplified. This shows that the DNA extraction method used is variable, this could 
be due to scientific error and or low bradyzoite cyst density within the muscle 
tissues tested. 
   In a surprising turn of events DNA sequencing of amplified products indicated 
that mispriming regularly resulted in incorrect products of a very similar size to 
those expected from amplification of T. gondii template. For example, both P30 
and SAG1 primer sets amplifies nonspecific products of almost identical size (125 
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and 127 base pairs, respectively) from beef, lamb and pork DNA extracts (see 
Figure 3.4.3 and 3.4.4 and sequence results in appendix).  
 
3.4.3  Genotyping PCR targets: 
   Initial attempts at amplification of T. gondii targets using genotyping targets 
such as SAG3, GRA6, NN1/2 and L358 failed to produce PCR products. By 
lowering the anneal temperature and increasing anneal time to 15s it was possible 
to produce PCR products but sequencing results (where possible) were poor and 
showed no evidence of the presence of T. gondii DNA. 
 
 
 
 
 
 
 
Figure 3.4.5 Lack of visible PCR products using Meat2 extracts with GRA6 
and SAG3 primers at an annealing temperature of 58°C. Lane 1-4: GRA6: 
Lane 1: Pork2, Lane 2: Lamb2, Lane 3: Beef3, Lane 4: GRA6 negative control. 
Lane 5-8 SAG3: Lane 5 Pork2, Lane 6: Lamb2, Lane 7: Beef2, Lane 8 SAG3 
negative control, Lane 9: Genescript™ 100bp DNA ladder. Visualised on a 2% 
agarose TAE gel containing 2µL Ethidium bromide (10mg/mL) 
Based on the melt points for each primer (IDT scitools), ‘Genotyping’ primers 
were tested against Meat2 template DNA. Annealing temperatures used were as 
close to 5C below the expected melt point as possible. This resulted in expression 
of L358 products only (see figure 3.4.7). Sequencing results for L358 products 
were poor and did not indicate the presence of T. gondii, but that mispriming had 
occurred. 
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Figure 3.4.6 Touchdown and gradient PCR of SAG3 NN1/2, L358 and GRA6 
primers with Meat2 extracts. Lanes 1-4 SAG3: Lane 1: Pork2, Lane 2: Lamb2, 
Lane 3: Beef2, Lane 4: negative control. Lane 5: Genescript ™ 100bp DNA 
ladder. Lanes 6-9: NN1/2: Lane 6: Pork2, Lane 7: lamb2, Lane 8: Beef2, Lane 9: 
NN1/2 negative control. Lanes 10-13 L-358: Lane 10 Pork2, Lane 11: Lamb2, 
Lane 12: Beef2. Lane 14: Genescript™ 100bp DNA ladder, Lanes15-18: GRA6: 
Lane 15: Pork2, Lane 16: Lamb2, Lane 17: Beef2, Lane 18 GRA6 negative 
control. Visualised on a 2% agarose TAE gel containing 2µL Ethidium bromide 
(10mg/mL) 
 
   By further decreasing annealing temperatures it was possible to obtain PCR 
products using GRA6 and SAG3 primer sets (see Figures 3.4.7 and 3.4.8 below), 
however multiple product bands indicate that these reactions are due to 
mispriming at suboptimal anneal temperatures. 
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Figure 3.4.7 Attempted amplification of Meat2DNA extracts using SAG3 and 
GRA6 primers. Lanes 1-4 GRA6: Lane 1: Pork2, Lane 2: Lamb2, Lane 3: Beef2, 
Lane 4: GRA6 negative control. Lane 5: Genescript™ 100bp DNA ladder, Lanes 
6-9: SAG3: Lane 6: Pork2, Lane 7: Lamb2, Lane 8 Beef2, Lane 9:SAG3 negative 
control. Visualised on a 2% agarose TAE gel containing 2µL Ethidium bromide 
(10mg/mL). 
 
 
 
 
 
 
 
 
Figure 3.4.8 L358 and SAG3 amplification from Meat2 DNA extracts. Lanes 
1-4: L358 amplifications. Lane 1 Pork2, Lane 2: Lamb2, Lane 3: Beef2, Lane 4: 
L358 negative control. Lane 5: Genescript™ 100bp DNA ladder. Lanes 6-9: 
SAG3 amplification. Lane 6: Pork 2, Lane 7: Lamb 2, Lane 8: Beef 2, Lane 9: 
SAG3 negative control. Visualised on a 2% agarose TAE gel containing 2µL 
Ethidium bromide (10mg/mL) 
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Figure 3.4.9 Amplification of Meat3 DNA extracts using SAG2 primers. Lane 
1: Pork3, Lane 2: Beef3, Lane 3: Beef3, Lane 4: Chicken 3. Lane 5 SAG2 
negative control. Lane 6 Solis biodyne™ 100bp DNA ladder. Visualised on a 2% 
agarose TAE gel containing 2µL Ethidium bromide (10mg/mL). 
   Beef and Lamb SAG2 products were sequenced but results were again 
disappointing, indicating amplification of host DNA not T. gondii (see sequencing 
results in appendix 2).  Where multiple distinct product bands were obtained 
attempts were made to gel purify these product bands. All such attempts at 
column purification of PCR product bands gave low quality sequence data, none 
of which corresponded to T. gondii target sequences (see the SAG2 example 
below and sequencing data in Appendix).  
   When it was found that genotyping primers were acting in nonspecific manner, 
giving multiple PCR product bands that were not useful for sequencing and where 
sequencing was possible, giving PCR products matching the host tissues primers 
specific to the apicoplast were trialled. The first primer set (API) targeting the 
apicoplast genome initialy gave encouraging results. Figure 3.4.11 (below) shows 
product bands aproximate in size to the 304bp expected product. However 
sequencing results were both indicative of mispriming with host DNA. (see 
Appendix 2). 
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Figure 3.4.10 API amplification of Meat2 DNA extracts. Lane 1: API Negative 
control, Lane 2: Genescript™ 100bp DNA ladder. Lane 3: Lamb2, Lane 4: Beef2. 
Visualised on a 2% agarose TAE gel containing 2µL Ethidium bromide 
(10mg/mL). 
 
 
 
 
 
 
 
 
Figure 43.4.11 API-184 amplification of Meat2 DNA extracts. Lane 1: Pork2, 
Lane 2: Lamb2, Lane 3: Beef2, Lane 4: API-184 negative control. Lane 5: 
Genescript™ 100bp DNA ladder. . Visualised on a 2% agarose TAE gel 
containing 2µL Ethidium bromide (10mg/mL). 
300bp 
          1                                           2                                            3                                            
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400bp 
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   A second and (according to primer blast) more specific apicoplast primer set 
(API-184) was used giving the results visible in Figure 3.4.11 (above). Although a 
faint product band of the expected 184bp) size is visible, multiple product bands 
indicates that significant mispriming has occurred. 
   In an attempt to increase the concentration of a PCR product band (Lane 2, 
Figure 3.4.12 below) attempts were made to re-amplify this product using a 
temperature titration to maximize specificity. The resulting PCR products can be 
seen in figure 3.4.13 below. Although a product band at 300bp was expected all 
reactions gave multiple products at a wide range of sizes. This indicates that gel 
purification of product bands does not preclude the presence of contamination 
with PCR products of unwanted sizes. This could in part explain the poor 
sequence data obtained using this method previously. No further attempts were 
made to sequence PCR product bands extracted from gel slices. 
 
 
 
 
 
 
 
 
Figure 3.4.12 SAG2 amplification of Beef2 and Lamb2 DNA extracts: Lane 1: 
Lamb2, Lane 2: Beef2, Lane 3 SAG2 negative control. Lane 4: Genescript™ 
100bp DNA ladder. Visualised on a 2% agarose TAE gel containing 2µL 
Ethidium bromide (10mg/mL). 
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Figure 3.4.13 Reamplification of gel purified high molecular mass SAG2 PCR 
product including a temperature titration. Visualised using a 2% agarose TAE 
gel containing 2µL Ethidium bromide. Annealing temperature at top. Ladder: 
Genescript™ 100bp DNA ladder. 
  
3.4.5  Nested PCR reactions: 
   Increased sensitivity and specificity were achieved using nested primer sets 
targeting regions of the SAG1 (SAG449FP30R/SAG1FSAG449R) and 18S (NN1-
2/ITS) loci (see methods). However nested PCR carries with it a much greater 
chance of contamination. Because of this any positive results were checked with a 
second nested set which had previously been shown to work well with the 
Toxovax™ positive control. 
   Amplification of SAG1 from DNA extracted from Beef6, Lamb6, Beef7 and 
Lamb7 was achieved using touchdown PCR protocols 71 and 70 (see figure 3.5). 
This result could not be confirmed using the second (NN1-2/ITS) nested PCR 
reaction (see figure 3.6). This discrepancy is likely due to contamination of the 
first nested reaction as both primer sets gave strong amplification with Toxovax© 
positive control. 
 
 
   55.9°C        57.1°C        58.0°C        59.0°C   
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Figure 3.4.14 SAG1 nested PCR products amplified from Meat6 and Meat7 
DNA extracts. Lane 1: Toxovax™ positive control, Lane 2: empty, Lane 3: 
Zebrafish negative control, Lane 4: Pork7, Lane 5: Lamb7, Lane 6: Beef7, Lane 7: 
Solis biodyne™ 100bp DNA ladder, Lane 8: Zebrafish negative control, Lane 9: 
Pork6, Lane 10 Lamb6, Lane 11: Beef6.Visualised on a 1% agarose SB gel 
containing 3µL Ethidium bromide. 
 
 
 
 
 
 
Figure 3.4.15 NN1/2-ITS nest of BEF6, Lamb6, Beef7 and Pork7.. Lane 1: 
Toxovax™ positive control, Lane 2: empty, Lane 3: Lamb7, Lane 4: Beef7, Lane 
5: Pork 6, Lane 6: Beef6, Lane 7: Zebrafish negative control. Lane 8: Solis 
biodyne™ 100bp DNA ladder. Visualised on a 1% agarose SB gel containing 3µL 
Ethidium bromide. 
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3.4.6  Overall Meat DNA Extract PCR results:  
   Amplification of T. gondii specific nucleotide sequences were attempted on gel 
purified (see methods) DNA extracts from 25 portions of beef, chicken, lamb and 
pork mince purchased from butchers and supermarkets from within the Hamilton 
area. The results are summarised in Tables 3.3 to 3.26 below. 
  Genotyping of T. gondii from commercially available meat samples using 
amplified polymorphic PCR targets such as SAG3, L368 and GRA6 was not 
possible, either owing to non-specific primer binding, the complete lack of 
T. gondii template DNA or extremely low T. gondii template concentration. 
   Overall these results show that if T. gondii is present in NZ farmed meat for sale 
in the Hamilton region, cyst density is lower than would have been predicted by 
overseas studies conducted in the United Kingdom (Aspinall et al., 2002) and in 
the USA (J. Dubey et al., 2005).  
 
 
Table 3.8 A summary of Beef1 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. (seq+) and (seq-) indicate positive and negative sequencing results 
(see Appendix 2 for detail). 
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Table 3.9 A summary of Lamb1 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. (seq+) and (seq-) indicate positive and negative sequencing results 
(see Appendix 2 for detail). 
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Table 3.10 A summary of Pork1 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. (seq+) and (seq-) indicate positive and negative sequencing results 
(see appendix for detail).  
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   Although the original Pork1 extract tested positive for T. gondii DNA, a further 
3 extracts were carried out (approximately 0.5 grams per extraction), no T. gondii 
DNA was detected using both nested and conventional PCR reactions. 
 
Table 3.11 A summary of Beef2 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. (seq+) or (seq-) show sequencing 
results. Bracketed numbers show nested PCR reactions. 
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Table 3.12 A summary of Lamb2 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. (seq+) and (seq-) indicate positive and negative sequencing 
results.  
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Table 3.13 A summary of Pork2 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. (seq+) and (seq-) indicate positive and negative sequencing 
results.  
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Table 3.14 A summary of Beef3 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. 
 
 
Table 3.15 A summary of Chicken3 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. (seq+) and (seq-) show positive and negative sequencing results 
(see Appendix 2 for detail).  
. 
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Table 3.16 A summary of Lamb3 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. (seq+) or (seq-) show sequencing 
results (see Appendix 2 for detail). Bracketed numbers indicate nested PCR 
reactions. 
 
 
 
Table 3.17 A summary of Pork3 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. 
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Table 3.18 A summary of Beef4 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. 
. 
 
Table 3.19 A summary of Lamb4 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. 
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Table 3.20 A summary of Pork4 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers indicate nested 
PCR reactions. 
 
Table 3.21 A summary of Beef5 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. (seq+) and (seq-) show positive and negative sequencing results 
(see Appendix 2 for detailed sequence data). 
 
Table 3.22 A summary of Chicken5 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. (seq+) and (seq-) show positive and negative sequencing results 
(see Appendix 2 for detailed sequence data). 
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Table 3.23 A summary of Lamb5 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. (seq+) and (seq-) show positive and negative sequencing results 
(see Appendix 2  for detailed sequence data).  
 
Table 3.24 A summary of Pork5 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
 
Table 3.25 A summary of Beef6 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
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Table 3.26 A summary of Lamb6 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
 
Table 3.27 A summary of Lamb6 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
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Table 3.28 A summary of Beef7 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
 
 
Table 3.29 A summary of Chicken7 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
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Table 3.30 A summary of Lamb7 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions 
 
Table 3.31 A summary of Pork7 PCR results with each primer set and 
thermocycler protocol trialled. N= no visible product. MP= multiple product 
bands visible. S= single product band visible. Bracketed numbers show nested 
PCR reactions. 
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Chapter Four 
Discussion 
 
4.1  Summary of DNA extraction and PCR assays 
4.1.1 Development of positive and negative PCR controls 
   A positive PCR control from a sample of Toxovax™ live toxoplasmosis vaccine 
for sheep was kindly donated by MSD animal health. Using proteinase K 
digestion followed by phenol-chloroform extraction DNA from this sample was 
gel purified, resulting in a DNA solution containing a large proportion of 
T. gondii DNA. This positive control was found to reliably amplify all but two of 
the primer sets selected for this study. A total of 18 primer sets were investigated. 
Failed amplification in one case (B1) was caused by an incorrect primer order 
(resulting from a misprint in reference literature), in the second case (SAG2), for 
unknown reasons. 
   The development of a negative control was more problematic. Proteinase K 
digestion followed by phenol-chloroform extraction and purification by gel 
electrophoresis was used to develop three separate negative PCR controls using 
DNA extracted from fish tissue. The first sample was from a freshwater fish of 
unknown species, the second from a section shark fin from a spotty dogfish, and 
the third from a Zebrafish. Contamination problems rendered to the first two 
specimens (miscellaneous fish and shark fin) were not overcome with PCR 
optimisation and good laboratory practice. The third negative control developed 
from purified Zebrafish DNA extract was more successful. This negative control 
showed no evidence of T. gondii sequence amplification with all primers tested 
however non-specific priming with GRA6 primers resulted in a PCR product (of a 
significantly different size to the T. gondii product expected). This non-specific 
product was confirmed as a Zebrafish specific sequence using DNA sequencing. 
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4.1.2  Feline Faecal DNA extraction  
   Development of a reliable faecal DNA extraction method was achieved only 
after methods were found to remove (Taq polymerase) inhibitory components. 
Section 3.2 provides a detailed description of the development of a feline faecal 
DNA extraction method. Initial trials demonstrated significant DNA yields but 
were not reliably amplifiable owing to unknown inhibitory contaminants. 
Treatment with chelex resin chelating solution was successful in some cases in 
removing these contaminants but this method was not consistently successful. 
Treatment with 1% activated charcoal was also found to be unsuccessful. A 
reliable DNA purification method was found to be treatment with 1% activated 
charcoal followed by purification  by gel electrophoresis. No sample purified in 
this manor failed to produce PCR products when trialled with 16Sr DNA bacterial 
specific primers to test for inhibition. 
4.1.3  Amplification of Faecal DNA extracts 
   Amplification of T. gondii specific sequences from faecal DNA extracts using 
SAG3 and GRA6 primer sets demonstrated a higher than expected rate of oocyst 
shedding in faecal samples (Section 3.2.1). This high rate of shedding could be 
explained by presence of feline leukaemia virus among feral cat populations. This 
virus compromises a cat’s ability to produce an effective immune response. This 
can lead to flourishing of existing chronic infection into secondary acute 
infections. An impaired immune response can also make felines much more 
susceptible to secondary infection upon consumption of infected prey leading to 
further oocyst shedding.  
4.1.4  Fresh Meat DNA extraction 
   DNA was extracted from twenty five mince samples (beef, chicken, lamb and 
pork) purchased from supermarkets and butchers shops from central Hamilton and 
Hamilton East. DNA was extracted from these samples using proteinase K 
digestion followed by phenol-chloroform extraction (Section 3.3.1). Initial DNA 
extracts were amplified using primer sets targeting tandem repeat regions such as 
B1, AF and TGR1E and single copy PCR targets P30 and SAG1 of the SAG1 gene. 
When electrophoresed, these PCR products showed broad product bands and 
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multiple bands of unexpected sizes. Results were significantly improved when 
(total) DNA extracts were purified by gel electrophoresis to give high molecular 
weight DNA fragments only. These purified DNA samples gave much clearer 
PCR product bands and far fewer bands of unexpected sizes. DNA yield was 
highest and most consistent from beef and lamb mince samples and more variable 
from pork mince. It was found that DNA yields from chicken mince was greatly 
improved by increasing proteinase K digest incubation time from three hours to 
20 hours.   
4.1.5  Amplification of DNA from fresh meat 
   Once a DNA extraction method had been settled upon, PCR products giving 
single bands of the expected size were purified and then sent for DNA sequencing 
analysis. Sequencing of one PCR product from the first pork DNA extract (pork1) 
amplified using primers targeting the P30 region of the SAG1 gene was found to 
be specific for T. gondii (99.9% grade). Although PCR products from other meat 
samples were obtained that appeared to be the same size as this product, 
sequencing results (although low quality) indicated that these were very probably 
Bos taurus sequences likely resulting from nonspecific primer binding. This initial 
positive result could not be repeated despite multiple further attempts. 
   Although amplification using primer sets targeting tandem repeat regions 
produced PCR products multiple product bands were always produced which 
made confirmation of these products impossible. Also, the banding patterns 
resulting from these PCR reactions did not match those produced when the same 
primer sets were trialled with the positive PCR control. 
   Multiple attempts were made to amplify T. gondii specific sequences using 
primer sets (sourced from literature) which targeted polymorphic regions used in 
genotyping studies. These primer sets (GRA6, SAG3, SAG2, L358) produced 
poor results in that where PCR reactions were achieved they regularly resulted in 
multiple products or where single products were obtained, sequencing results 
indicated that these were a result of non-specific primer binding. Attempts were 
made to cut product bands from gels and purify them for sequencing. These 
attempts resulted in very poor quality sequence data, if any. 
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   An apicoplast specific DNA sequence was targeted for PCR using the primer set 
API. Sequencing results from the PCR products produced using these primers 
indicated amplification had occurred as a result of non-specific primer binding. 
   As primer sets sourced from literature had produced multiple products or 
products shown to be a result of non-specific primer binding, NCBI primer blast 
was used to design new specific primer sets (API-184, B1-463 and SAG1-449) 
with the intention of preventing amplification from any of the host tissues 
(Bos taurus, Gallus gallus, Aries ovis and Sus scrofa as well as Homo sapiens). 
Although API-184 produced PCR products, sequencing results showed these were 
a result of non-specific primer binding. B1-463 and SAG1-449 primers did not 
produce any PCR products in the small number of reactions attempted; however, 
SAG449 forward and reverse primers were useful in developing a nested PCR 
method to target the SAG1 gene.  
4.1.6  Nested PCR 
   Both SAG1 and 18S regions were targeted using nested PCR reactions (Section 
3.3.5). The nested set, (outer)SAG-449F/P30R and (inner)SAG1F/449R was 
chosen above other options for amplifying SAG1 as this gave a larger product size 
than other options available. Thus, making confirmation of PCR product identity 
by sequencing more reliable. This set was shown to work well with Toxovax™ 
positive PCR. The nested set, (outer)NN1/2 and (inner)ITS was used to target an 
internally transcribed region of the 18S gene and was also found to work well with 
Toxovax™ positive PCR control. 
  When used with meat DNA extracts these (nested) primer sets gave negative 
results in most cases. Contamination of eleven meat DNA extracts resulted in 
strong positive results which were later discounted following a repeat of DNA 
extractions using fresh reagents. In four cases (Beef6, Pork6, Beef7 and Lamb7) 
positive results were obtained using the nested set targeting SAG1 and were 
confirmed by sequencing. These results were discounted as the result of 
contamination when negative results were obtained using the nested set targeting 
the 18S region gave negative results. This discrepancy in results highlights the 
additional risk of nested PCR techniques relative to single stage PCR. 
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4.2 Conclusions 
Given the findings of this study it can be concluded that: 
   Toxovax™ cultured in THP-1 human monocytic cell culture provides an 
adequate T. gondii DNA yield to act as an effective positive PCR control for 16 of 
the 18 primer sets trialled. 
   GITC homogenisation followed phenol chloroform DNA extraction, charcoal 
treatment and gel purification allowed the extraction of sufficient DNA from the 
faeces of both domestic and feral Felis catus to allow testing for the presence of 
T. gondii oocyst shedding using PCR techniques. 
   PCR results showing amplification of both SAG3 and GRA6 target sequences 
which were confirmed using sequencing and restriction enzyme digests 
demonstrated that DNA extracts from Felis catus faecal samples contained a 
much greater than anticipated rate of oocyst shedding among the feral cat 
population from the Raglan area than would be expected in healthy populations. 
   Proteinase K digestion of raw meat samples followed by phenol chloroform 
DNA extraction and gel purification provides a reliable method for the extraction 
and purification of high molecular weight DNA from raw Areis ovis, Bos taurus, 
Gallus gallus and Sus scrofa muscle tissue. When applied to muscle tissue 
samples ranging in mass from 0.3g to 0.5g this method of DNA extraction was not 
able to consistently produce a DNA template that could provide evidence of the 
presence of intracellular bradyzoite T. gondii cysts using the 18 primer sets 
trialled. 
   T. gondii DNA was detected in one of the raw New Zealand farmed meat 
samples tested however which shows that T. gondii contamination within New 
Zealands domestic meat supply is possibly rare. This observation may reflect an 
inefficient DNA extraction procedure and less than optimal primer choice for 
DNA amplification for meat extracts. 
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4.3 Future recommendations 
   For this thesis, four DNA extraction protocols were tested and optimised for 
PCR detection of detection of T. gondii in fresh New Zealand farmed meat. In 
addition, suitable negative and positive controls were developed. Out of the 
twenty five meat samples tested using our developed PCR assay, only one sample 
was positive for T. gondii. Therefore, it is recommended that a larger sample set 
be analysed along with alternative DNA extraction methodologies that will 
efficiently extract DNA from larger sample sizes to increase the likelihood of 
including the DNA from what may be relatively widely distributed muscle cell 
bradyzoite cysts. In addition, use of deliberately infected livestock or livestock 
that have been determined to be carrying a chronic T. gondii infection through 
serological testing as positive controls to test for PCR assay effectiveness may be 
extremely valuable. 
   Although a large amount of research has been carried out studying the parasite 
Toxoplasma gondii since its discovery over a century ago (J. P. Dubey, 2008) 
there is much still to be learned about this small but complex organism. Areas still 
not well understood are virulence factors such as the means by which this parasite 
is able to permeate throughout the tissues of the host and mask itself from host 
immune responses(Lambert, Hitziger, Dellacasa, Svensson, & Barragan, 2006), 
the mechanisms by which the parasite is able to effect host neurology to alter host 
behaviour (Jaroslav Flegr & Markoš, 2014) and how it has become so widespread 
throughout animal populations (Jensen, Aars, Lydersen, Kovacs, & Åsbakk, 2010).  
   The mechanisms that determine virulence are only partially understood. Key to 
T. gondii virulence are the mechanisms by which the parasite is able to manipulate 
host immune responses. These have been examined through comparison of strains 
and crosses have demonstrated the effect of several genetic polymorphisms which 
influence the relative virulence of various strains (Hunter & Sibley, 2012a). 
However, these techniques are somewhat limited when compared with the 
potential of forward genetic approaches such as gene knockout or targeted 
mutation of existing genes. Relative virulence is also influenced by the ability of 
T. gondii tachyzoites to influence the gene expression of host leukocytes in order 
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to permeate into host tissues such as the central nervous system and the retina 
which would ordinarily remain insulated from blood born infections. Although 
this effect has been observed (Weidner & Barragan, 2014), the induced changes in 
gene expression responsible are yet to be elucidated. Careful comparison of 
transcriptomes from both infected (with known T. gondii genotypes) and 
uninfected leukocyte and microglia populations may in future demonstrate if not 
quantify the changes in gene expression responsible for these changes in cell 
activity and the mechanisms responsible for these changes. 
   The variation in virulence between the myriad strains/admixtures of T. gondii 
makes the examination of population distributions an important consideration as 
data from such studies could play important roles in treatment strategies in cases 
of congenital toxoplasmosis infection, infections resulting from organ transplants, 
and toxoplasmosis infections in patients with HIV/AIDS. 
   Variations in virulence also play an important role when considering the effects 
of T. gondii upon wildlife populations. The development of the Toxovax™ live 
vaccine for sheep relied upon such species specific differences in virulence. This 
strain of T. gondii was sourced from the coteledon of an aborted lamb and over 
many generations of culturing in murine cells the strain evolved in such a way that 
while remaining pathogenic to mice was no longer dangerous to gestating lambs 
and forms no observable chronic (bradyzoite cyst) infection.  
   Recent research has shown that T. gondii infects many species of marine 
mammals (Jardine & Dubey, 2002; Lambourn, Jeffries, & Dubey, 2001) and may 
be playing a significant role in the decline in New Zealand native Hectors and 
Maui dolphins (Roe, Howe, Baker, Burrows, & Hunter, 2013). An ongoing study 
into deaths of native Hector and Maui dolphins has shown that a majority of these 
native cetaceans are infected with T. gondii and in many cases is thought to be the 
cause of death. At present, researchers in this area speculate that these species 
become infected due to feeding in shallow waters around river mouths carrying 
oocysts in water runoff (Roe et al., 2013). 
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  Other whale and dolphin populations have also been observed to carry 
toxoplasmosis infections (including the arctic beluga whale). The mode of 
parasite transmission to such a seemingly isolated (from felidae primary hosts) 
population bears the question of how T. gondii can be transmitted throughout food 
chains. Observations so far have shown that bicuspid filter feeders such as 
mussels can accumulate sporylated oocysts and this is thought to be the mode of 
infection of pacific sea otters (Miller et al., 2008). For toothed whales such as the 
beluga to become infected implies that they are either preying upon migratory 
secondary hosts such as other marine mammals or that T. gondii oocysts are able 
to accumulate in fish populations which has never been observed. (currently T. 
gondii is not known to infect any cold blooded species). Although soil and water 
testing for sporylated oocysts has been demonstrated a much greater 
understanding of modes of environmental transmission provides many potential 
areas for further research. 
   As filter feeders have been shown to accumulate oocysts, such species may 
provide an convenient avenue of investigation for the presence of oocysts within 
hector and maui dolphin feeding grounds. By strategically placing colonies of 
such organisms in such areas for short periods, large volumes of water would be 
filtered and oocysts present could be tested for subsequently either though 
bioassay or through PCR. 
 
 
 
  
    88 
References 
 
Alfonso, Y., Fraga, J., Cox, R., Jiménez, N., Capó, V., Pomier, O., . . . Calá, V. (2013). 
Conventional polymerase chain reaction for the diagnosis of 
neurotoxoplasmosis: comparison of three sets of primers for the B1 gene using 
CSF samples. Diagnostic microbiology and infectious disease, 75(2), 150-154.  
Asai, T., Miura, S., Sibley, L. D., Okabayashi, H., & Takeuchi, T. (1995). Biochemical and 
molecular characterization of nucleoside triphosphate hydrolase isozymes 
from the parasitic protozoan Toxoplasma gondii. Journal of Biological 
Chemistry, 270(19), 11391-11397.  
Aspinall, T. V., Marlee, D., Hyde, J. E., & Sims, P. F. (2002). Prevalence of Toxoplasma 
gondii in commercial meat products as monitored by polymerase chain 
reaction–food for thought? International Journal for Parasitology, 32(9), 1193-
1199.  
Bretagne, S., Costa, J. M., Vidaud, M., Van Nhieu, J. T., & Feith, J. F. (1993). Detection 
of Toxoplasma gondii by competitive DNA amplification of bronchoalveolar 
lavage samples. Journal of Infectious Diseases, 168(6), 1585-1588.  
Costa, J.-M., Alanio, A., Moukoury, S., Clairet, V., Debruyne, M., Poveda, J.-D., & 
Bretagne, S. (2013). Direct genotyping of Toxoplasma gondii from amniotic 
fluids based on B1 gene polymorphism using minisequencing analysis. BMC 
infectious diseases, 13(1), 552.  
Costa, J.-M., & Bretagne, S. (2012). Variation of B1 gene and AF146527 repeat element 
copy numbers according to Toxoplasma gondii strains assessed using real-time 
quantitative PCR. Journal of clinical microbiology, 50(4), 1452-1454.  
Dubey, J. (2009). History of the discovery of the life cycle of Toxoplasma gondii. 
International Journal for Parasitology, 39(8), 877-882.  
Dubey, J., Hill, D., Jones, J., Hightower, A., Kirkland, E., Roberts, J., . . . Miska, K. (2005). 
Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail 
meat stores in the United States: risk assessment to consumers. Journal of 
Parasitology, 91(5), 1082-1093.  
Dubey, J., Lindsay, D., & Speer, C. (1998). Structures of Toxoplasma gondiitachyzoites, 
bradyzoites, and sporozoites and biology and development of tissue cysts. 
Clinical microbiology reviews, 11(2), 267-299.  
Dubey, J. P. (2008). The history of Toxoplasma gondii—the first 100 years. Journal of 
Eukaryotic Microbiology, 55(6), 467-475.  
Fekadu, A., Shibre, T., & Cleare, A. J. (2010). Toxoplasmosis as a cause for behaviour 
disorders - overview of evidence and mechanisms. [Review]. FOLIA 
PARASITOLOGICA, 57(2), 8.  
Flegr, J. (2013). Influence of latent Toxoplasma infection on human personality, 
physiology and morphology: pros and cons of the Toxoplasma-human model 
in studying the manipulation hypothesis. [Review]. The Journal of 
Experimental Biology, 216, 6. doi: 10.1242/jeb.073635 
Flegr, J., & Markoš, A. (2014). Masterpiece of epigenetic engineering–how Toxoplasma 
gondii reprogrammes host brains to change fear to sexual attraction. 
Molecular ecology, 23(24), 5934-5936.  
Grillo, R., Gross, U., Hayde, M., Holliman, R., Ho-Yen, D., Janitschke, K., . . . Thulliez, P. 
(1999). The past and present role of the Sabin±Feldman dye test in the 
    89 
serodiagnosis of toxoplasmosis. Bulletin of the World Health Organization, 
77(11).  
Hunter, C. A., & Sibley, L. D. (2012a). Modulation of innate immunity by Toxoplasma 
gondii virulence effectors. [10.1038/nrmicro2858]. Nat Rev Micro, 10(11), 766-
778. doi: 
http://www.nature.com/nrmicro/journal/v10/n11/suppinfo/nrmicro2858_S1.
html 
Hunter, C. A., & Sibley, L. D. (2012b). Modulation of innate immunity by Toxoplasmosa 
gondii virulence effectors. [Review]. Nature, 10(November), 12. doi: 
10.1038/nrmicro2858 
Jardine, J., & Dubey, J. (2002). Congenital toxoplasmosis in a Indo-Pacific bottlenose 
dolphin (Tursiops aduncus). Journal of Parasitology, 88(1), 197-199.  
Jauregui, L., Higgins, J., Zarlenga, D., Dubey, J., & Lunney, J. (2001). Development of a 
real-time PCR assay for detection of Toxoplasma gondii in pig and mouse 
tissues. Journal of clinical microbiology, 39(6), 2065-2071.  
Jensen, S., Aars, J., Lydersen, C., Kovacs, K., & Åsbakk, K. (2010). The prevalence of 
Toxoplasma gondii in polar bears and their marine mammal prey: evidence for 
a marine transmission pathway? Polar biology, 33(5), 599-606.  
Khan, A., Böhme, U., Kelly, K. A., Adlem, E., Brooks, K., Simmonds, M., . . . 
Chillingworth, T. (2006). Common inheritance of chromosome Ia associated 
with clonal expansion of Toxoplasma gondii. Genome research, 16(9), 1119-
1125.  
Khan, A., Taylor, S., Su, C., Mackey, A. J., Boyle, J., Cole, R., . . . Berriman, M. (2005). 
Composite genome map and recombination parameters derived from three 
archetypal lineages of Toxoplasma gondii. Nucleic acids research, 33(9), 2980-
2992.  
Kocazeybek, B., Oner, Y., Turksoy, R., Babur, C., Cakan, H., Sahip, N., . . . Torun, M. 
(2009). Higher prevalence of toxoplasmosis in victims of traffic accidents 
suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of 
isanbul and its suberbs. [Study]. Forensic Science International, 187, 6.  
Lambert, H., Hitziger, N., Dellacasa, I., Svensson, M., & Barragan, A. (2006). Induction 
of dendritic cell migration upon Toxoplasma gondii infection potentiates 
parasite dissemination. Cellular microbiology, 8(10), 1611-1623.  
Lambourn, D., Jeffries, S., & Dubey, J. (2001). Seroprevalence of Toxoplasma gondii in 
harbor seals (Phoca vitulina) in southern Puget Sound, Washington. Journal of 
Parasitology, 87(5), 1196-1197.  
Lehmann, T., Marcet, P. L., Graham, D. H., Dahl, E. R., & Dubey, J. (2006). Globalization 
and the population structure of Toxoplasma gondii. Proceedings of the 
National Academy of Sciences, 103(30), 11423-11428.  
Malmasi, A., Mosallanejad, B., Mohebali, M., Sharifian Fard, M., & Taheri, M. (2009). 
Prevention of Shedding and Re‐Shedding of Toxoplasma gondii Oocysts in 
Experimentally Infected Cats Treated with Oral Clindamycin: A Preliminary 
Study. Zoonoses and public health, 56(2), 102-104.  
Meissner, M., Schlüter, D., & Soldati, D. (2002). Role of Toxoplasma gondii myosin A in 
powering parasite gliding and host cell invasion. Science, 298(5594), 837-840.  
Melo, M. B., Jensen, K. D. C., & Saeij, J. P. J. (2011). Toxoplasma gondii effectors are 
master regulators of the inflammatory response. [Rveview]. Trends in 
parasitology, 27(11), 6.  
Miller, M., Miller, W., Conrad, P., James, E., Melli, A., Leutenegger, C., . . . Harris, M. 
(2008). Type X Toxoplasma gondii in a wild mussel and terrestrial carnivores 
    90 
from coastal California: new linkages between terrestrial mammals, runoff and 
toxoplasmosis of sea otters. International Journal for Parasitology, 38(11), 
1319-1328.  
Minot, S., Melo, M. B., Li, F., Lu, D., Niedelman, W., Levine, S. S., & Saeij, J. P. (2012). 
Admixture and recombination among Toxoplasma gondii lineages explain 
global genome diversity. Proceedings of the National Academy of Sciences, 
109(33), 13458-13463.  
Nicolle, C., & Manceaux, L. (1908). Sur une infection à corps de Leishman (ou 
organismes voisins) du gondi. CR Acad Sci, 147(763).  
Ong, Y.-C., Reese, M. L., & Boothroyd, J. C. (2010). Toxoplasma rhoptry protein 16 
(ROP16) subverts host function by direct tyrosine phosphorylation of STAT6. 
Journal of Biological Chemistry, 285(37), 28731-28740.  
Pappas, G., Roussos, N., & Falagas, M. E. (2009). Toxoplasmosis snapshots: global 
status of Toxoplasma gondii seroprevalence and implications for pregnancy 
and congenital toxoplasmosis. International Journal for Parasitology, 39(12), 
1385-1394.  
Reese, M. L., Zeiner, G. M., Saeij, J. P., Boothroyd, J. C., & Boyle, J. P. (2011). 
Polymorphic family of injected pseudokinases is paramount in Toxoplasma 
virulence. Proceedings of the National Academy of Sciences, 108(23), 9625-
9630.  
Reischl, U., Bretagne, S., Krüger, D., Ernault, P., & Costa, J.-M. (2003). Comparison of 
two DNA targets for the diagnosis of Toxoplasmosis by real-time PCR using 
fluorescence resonance energy transfer hybridization probes. BMC infectious 
diseases, 3(1), 7.  
Robben, P. M., Mordue, D. G., Truscott, S. M., Takeda, K., Akira, S., & Sibley, L. D. 
(2004). Production of IL-12 by macrophages infected with Toxoplasma gondii 
depends on the parasite genotype. The Journal of Immunology, 172(6), 3686-
3694.  
Roe, W., Howe, L., Baker, E., Burrows, L., & Hunter, S. (2013). An atypical genotype of 
Toxoplasma gondii as a cause of mortality in Hector's dolphins 
(Cephalorhynchus hectori). Veterinary parasitology, 192(1), 67-74.  
Rosowski, E. E., Lu, D., Julien, L., Rodda, L., Gaiser, R. A., Jensen, K. D., & Saeij, J. P. 
(2011). Strain-specific activation of the NF-κB pathway by GRA15, a novel 
Toxoplasma gondii dense granule protein. The Journal of experimental 
medicine, 208(1), 195-212.  
SAFFER, L. D., MERCEREAU‐PUIJALON, O., DUBREMETZ, J. F., & SCHWARTZMAN, J. D. 
(1992). Localization of a Toxoplasma gondii rhoptry protein by 
immunoelectron microscopy during and after host cell penetration. The 
Journal of protozoology, 39(4), 526-530.  
Schroder, K., & Tschopp, J. (2010). The inflammasomes. Cell, 140(6), 821-832.  
Sibley, L. D., Khan, A., Ajioka, J. W., & Rosenthal, B. M. (2009). Genetic diversity of 
Toxoplasma gondii in animals and humans. Philosophical Transactions of the 
Royal Society B: Biological Sciences, 364(1530), 2749-2761.  
Su, C., Khan, A., Zhou, P., Majumdar, D., Ajzenberg, D., Dardé, M.-L., . . . Dubey, J. P. 
(2012). Globally diverse Toxoplasma gondii isolates comprise six major clades 
originating from a small number of distinct ancestral lineages. Proceedings of 
the National Academy of Sciences, 109(15), 5844-5849.  
Weidner, J. M., & Barragan, A. (2014). Tightly regulated migratory subversion of 
immune cells promotes the dissemination of< i> Toxoplasma gondii</i>. 
International Journal for Parasitology, 44(2), 85-90.  
    91 
Weir, R., Jennings, L., Young, S., Brunton, C., & Murdoch, D. (2009). National 
serosurvey of vaccine preventable diseases. Ministry of Health, Wellington.  
Wendte, J. M., Gibson, A. K., & Grigg, M. E. (2011). Population genetics of< i> 
Toxoplasma gondii</i>: New perspectives from parasite genotypes in wildlife. 
Veterinary parasitology, 182(1), 96-111.  
Yamamoto, M., Standley, D. M., Takashima, S., Saiga, H., Okuyama, M., Kayama, H., . . 
. Matsuda, T. (2009). A single polymorphic amino acid on Toxoplasma gondii 
kinase ROP16 determines the direct and strain-specific activation of Stat3. The 
Journal of experimental medicine, 206(12), 2747-2760.  
Zhou, X. W., Kafsack, B. F. C., Cole, R. N., Beckett, P., Shen, R. F., & Carruthers, V. B. 
(2005). The Opportunistic Pathogen Toxoplasma gondii Deploys a Diverse 
Legion of Invasion and Survival Proteins. Journal of Biological Chemistry, 
280(40), 34233-34244. doi: 10.1074/jbc.M504160200 
 
 
 
 
 
 
 
 
  
    92 
Appendix 1 – Recipes and consumables 
 
Geneaid DNA pure gel extraction kit 
http://www.geneaid.com/products/dna-ultra-pure/dna-pure-kit-dp100-dp300 
 
SDS Lysis Solution 
5 mls 1M Tris (APS) solution, pH 9 
5 mls 0.5 M EDTA (Ethylenediamine tetra acetic acid , Scharlau) solution, 
pH 8 
5 mls 10 % SDS (Roche) solution 
1 ml 5 M NaCl solution 
Made up to 50 ml with MQ-H2O 
 
5M GITC Solution 
295.4 g Guanidine thiocyanate (Sigma) 
2.5 g Sakanosyl (aka: N-Lauroylsarcosine sodium salt, Sigma) 
3.9 g tri-Sodium citrate (BDH) 
3.6 ml 2-mercaptoethanol (Scharlau) 
Made up to 500 ml with MQ-H2O 
pH to 7.0 with ~ 0.5 ml 1M NaOH 
 
Pepsin HCl 
5mL 0.1M HCl 
50mg NaCl 
0.7mg Pepsin 
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Proteinase K 60U/ml working solution 
Proteinase K (recombinant) PCR grade Roche® 30U/mg 
For 5mL @ 60 U/mL: 
2.5ml glycorol 
0.05ml Tris 
0.0145g CaCl 
2.5ml H2O 
10mg Proteinase K 
 
CTAB (10%) 
5g CTAB 
MQ H20 to 50mL 
 
5M LiCl 
212 g LiCl / litre MQ H20 
 
TE buffer 
Tris stock solution 1M: 6.07g/50mL H2O 
EDTA solution 0.5M 9.3125g/50mL H20 
TE buffer : 10mM Tris + 1mM EDTA + 10mM tris (500µL 1M Tris + 100µL 
0.5M EDTA + 50mL H2O) 
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Agarose 
Metaphor® agarose, FMC bioproducts 
 
TAE electrophoresis buffer 
TAE Running Buffer 
50 x stock solution 
242 g Tris (MW 121.14 g/mol, APS) 
100 ml 0.5 M EDTA (Ethylenediamine tetra acetic acid , Scharlau) solution, 
pH 8 
57.1 ml acetic acid (MW 60.05 g/mol, Ajax) 
Made up to 1 L in ddH2O 
Diluted to 1 x in ddH2O for working solution 
Working solution final concentrations: 
40 mM Tris 
1 mM EDTA 
20 mM acetic acid 
 
 
SB electrophoresis buffer 
SB Running Buffer 
10 x stock solution 
56 g boric acid (MW 61.83 g/mol, Ajax) 
10 g NaOH (sodium hydroxide, MW 40.0 g/mol, Ajax) 
Made up to 2 L in ddH2O 
pH should be at 8.5 
Dilute to 1 x in ddH2O for working solution 
Working solution final concentrations: 
    95 
45 mM boric acid 
12.5 mM NaOH 
 
Chelex solution (5%) 
40ml TE 
40ml MQ H20 
4g Chelex resin (200-400 mesh) 
 
Taq polymerase and mastermix !!! 
 
Primer suppliers and preparation: 
IDT® integrated DNA technologies 
Solubilised in MQ H2O to give 200pmol/L 
F=R primers diluted 1:50 with TE buffer to give 5pmol/L working solution 
 
Quickclean II gel extraction kit 
DNA pure gel extraction kit 
 
Genescript® 6x loading buffer with Gelred  
(http://www.genscript.com/molecule/M00120-
6X_Loading_Buffer_with_GelRed.html) 
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PEG solution 
20%/vol polyethylene glycol 
2.5M NaCl 
 
(other stock solutions?) 
 
Alkaline phosphate and exonuclease 
ROCHE rAPid alkaline phosphatase 
Thermo Fisher Scientific Fermentas exonuclease 1 
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Appendix 2 – PCR target sequences 
Expected PCR product sequences sourced from reference genome ME49 where 
possible: 
 
TGR1E 
ATGGTCCGGCCGGTGTATGATATGCGATTCGTCGAGTGCATGCACGGA
TGGGTGAGAGGTTACTGGTTGTGTGTCGTTATGCAGTCTGTCTGGGAG
ATGGTCGGGCGTATTGCCCAGGCGCCGGAGATGTTAGAAGAAAAGGT
TGCGGGACGTGTGGTGTGTCTCGAGGCAACTGCGGCACCACGTAGGGA 
 
 
TGRE1 
AGGGACAGAAGTCGAAGGGGACTACAGACGCGATGCCGCTCCTCCAG
CCGTCTTGGAGGAGAGATATCAGGACTGTAGATGAAGGCGACGGTGA
GGATGAGGGGGTGGCGTGGTTGGGAAGCGACGAGAGTCGGAGAGGGA
GAAGATGTTTCCGGCTTGGCTGC 
 
 
B1: AF179871 
TGTTCTGTCCTATCGCAACGGAGTTCTTCCCAGACGTGGATTTCCGTTG
GTTCCGCCTCCTTCGTCCGTCGTAATATCAGGCCTTCTGTTCTGTTCGCT
GTCTGTCTAGGGCACCCTTACTGCAAGAGAAGTATTTGAGGTCATATC
GTCCCATGAAGTCGACCACCTGTTTCCTCTCTTCACTGTCACGTACGAC
ATCGCATTCAAGGGAAGAGATCCAGCAGATCTCGTTCGTGTATTCGAG
ACAAGAGAGGTCCGCCCCCACAAGACGGCTGAAGAATGCAACATTCT
TGTGCTGCCTCCTCTCATGGCAAATGCCAGAAGAAGGGTACGTGTTGC
ATCATAACAAGAGCTGTATTTCCCGCTGGCAAATACAGGTGAAATGTA
CCTCCAGAAAAGCCACCTAGTATCGTGCGGCAATGTGCCACCTCGCCT
    98 
CTTGGGAGAAAAAGAGGAAGAGACGCTGCCGCTGTTTTGCAAATGAA
AAGGATTCATTTTCGCAGTACACCAGGAGTTGGATTTTGTAGAGCGTC
TCTCTTCAAGCAGCGTATTGTCGAGTAGATCAGAAAGGAACTGCATCC
GTTCATGAGTATAAGAAAAAAATGTGGGAATGAAAGAGACGCTAATG
TGTTTGCATAGGTTGCAGTCACTGACGAGCTCCCCTCTGCTGGCGAAA
AGTGAAATTCATGAGTATCTGTGCAACTTTGGTGTATTCGCAGATTGGT
CGCCTGCAATCGATAGTTGACCACGAACGCTTTAAAGAACAGGAGAA
GAAGATCGTGAAAGAATACGAGAAGAGGTACACAGAGATAGAAGTCG
CTGCGGAGACAGCGAAGACTGCGGATGACTTCACTCCCGTCGCACCAG
CAGCAGAGGAGTGCCGGGCAAGAAAATGAGATGCCTAGAGGAGACAC
AGCGTGTTATGAACAAATCTATTGAGGTTTCGCGAAGAGGAGGGAAC
ATATTATATACAGAAGAAGAACAAGAGACGTGCCGCATGTCGCTAAG
CCATCGGAAGGGATGCTCAGAAAATGGCACAGTATCACATTACAGTTC
CGTTGATTCGTCTGATGGTGACGAAAGGGGAAGAATAGTTGTCGCACC
AAAACTGGCTAGTTGTTATTTTGAAGAAGACGAGAGATGGAGTGAACC
ACCAAAAATCGGAGAAAATCGATGGTGTCACGTTTTTTGTCAGACTTC
ACTTTGTGCAGAAGCATTGCCCGTCCAAACTGCAACAACTGCTCTAGC
GTGTTCGTCTCCATTCCGTACAGTCTTCAAAAATACAAAAGAGAACAT
TCCAGCAACTTCTGCCTTTGTTCTTTTAGCCTCAATAGCAGGATGACGC
CTCCCTCCTATCTTTCAGCCAACCCAGCAAACACCGACGAACTCTCTGT
AGAGTAACAAAGAGAAGGCAAAACGCGCCATCACGAACACTCGCAGA
GATGATACAGAGACGTGTCATCAGGACAAGGTTGGTCGCTTAATTTTC
TGTATATAGCATTTTTAGAATGCACCTTTCGGACCTCAACAACCGTGCA
AAAGGATCGCCACCTGGTGTCTCTTCAAGCGTCAAAACGAACTATCTG
TATATCTCTCAAGGAGGACTGGCAACCTGGTGTCGACAACAGAACAGC
TGCAGTCCGGAAATAGAAAGCCATGAGGCACTCCAACGGGCGAGTAG
CACCTGAGGAGATACAAACTGCTAAACGGTCCGGGTGAAACAATAGA
GAGTACTGGAACGTCGCCGCTACTGCCCAGTTGTCATGCCATCGACGT
AGACCCA 
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SAG1: 
CTGATGTCGTTCTTGCGATGTGGCGCTATGGCATCGGATCCCCCTCTTG
TTGCCAATCAAGTTGTCACCTGCCCAGATAAAAAATCGACAGCCGCGG
TCATTCTCACACCGACGGAGAACCACTTCAC 
 
 
P30 
AGTTCCAATCGAGAAGTTCCCCGTGACAACGCAGACGTTTGTGGTCGG
TTGCATCAAGGGAGACGACGCACAGAGTTGTATGGTCACAGTGACAGT
ACAAGCCAGAGCCTCATCGGTCGTCAATAA 
 
 
SAG3: 
CAACTCTCACCATTCCACCCGGCGGGTTCCCCGAAGAAGACAAATCTT
TTCTTGTCGGGTGTTCACTCACTGTGGACGGGCCGCCCTTCTGCAACGT
CAAAGTGAGAGTTGCTGGGAACCCCAGAAAGTGGGAGAGGGGCGGAG
GCGGCCATCCAGGAAGCGGAGGATTGCAGCCAGGAACTGACGGGGAA
ACTCAAGCTGGAACAGGAAGTTCAGCCGGCGCGAGTTCGCGAATGGC
TTCCGTTGCCCTGGCGTTCCTTCTCGGTCTCCTTGTGCATGTGGCTGCCT
AAATGTCTTGTCTAACAACGCGC 
 
 
 
NN1/2: 
CCTTTGAATCCCAAGCAAAACATGAGTTTGCATCTCTCTCCATTGGAG
AGATTTGCATTCAAGAAGCGTGATAGTATCGAAAGGTATTATTGCCTT
CTTCATGTTGGATATCCTGCGCTGCTTCCAATATTGGAAGCCAGTGCAG
GTATCCGGGGGTGCACAGCGAAGGGGCTCAATTTCTGGAAATTCGTGT
CTCTGTTGGGATACTGATTTCCAGGAGTTTCTTCAGTGTGCATTCTTTTT
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TCCCACACCGTTATTTCAAACAACAAATCTGAGGAACATTTGAGAGAG
AGTGAAAGATTGTATCTTTCTGCATCTCTCTCGATGTGCTTTCAGATTG
CTTCCTAAACTATAATGTTATTTTAAATTTTCAGCAATGGATGTCTTGG
CTCGC 
 
 
L358:                                                               
CCCTCTGGCTGCAGTGCTGCGTCTTGGCCCTGCAAGGGTGCGAGTCTCT
GCTCTTCCGGACGACACACTCGCATGCATGTCCTCTTTCTGCCTTCGGC
TTGTCGGATGCGTCCTGTCGGGGGAACGGAGCCTCTTCGTCTTCCCCGC
TTCCTTCGCTCGGCTGCGCGTCGACGCTGCAATGTCGCGCGGCCACCC
CGCTGATAGACAAGAAGGCGAGGAGAGAGGCAGAGATCAGTTTCTCC
TGCATTCGCCTGCCGCCTCTCTCGCGACTCGTTTCGGACGGAGAAGCG
GGGAGAGAAGCGAGCGACGAGACAGCGACGGAAACCGCGCAGCAGG
AAGGTTTCGCTTTCTCCGCCCGTGTCGAGGAAGAGAACATTCCATTCTT
CGCGGCATGCTGCGACTTGCGCTACGCCTCCT 
 
 
UPRT: 
ACTGCGACGACATACTGGAGAACTCGAGCATCCTTTATGGGTTGGTGT
TGATGAACGTAGGACTACCAGATGTCATTTCTTCATTGGAACACTTTAT
TGTACACGCATGCCGTTTATGCGCTGCTTATCCGAGGGTGGCATCACA
GGGACCCTACAAGAAGCTGACGGGGCACCTCCACTATGAAGTGACAT
GCCAATTCATGCCCAGGTTGCATGTTCCAAGTGTCTGGTATCTTTGGCT
ACGCTGTCTTTTACTAATCGCAAGAAACAGTGCTCGTCATGGGTGGTA
ACTCCTTGGTGCCACCAGAACGCATGTGGTGCGTTTGTTGTTCCGCTTT
GTTTTCTTG 
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API: 
TCTATTGCAATGGAAAAAGGTATGAGATTTGCTATTAGAGAAGGAGGT
CGTACTATAGGAGCAGGTATAATTACTGATATTATAAAATAATAATTT
TATTATGAATAAAAAAAAAGTTATTATAAATAAATTAAAAAAACAAA
AAAATTTTTATTTAAATTTAAGATATTTATATTTAAAACAACTATCTAA
TTGAAATAATAAAATTTTTAATTTTATTAAATTAAAATAATTATAATTA
AAATGTTGAAAATCAGAATTGAACTGATAACTTAAGGATCTTCAGTCC
TTTGCTCTACCATTGA 
 
 
API-184: 
TGGTTTTAACCCTAGATTGTGGTTCTAGTTATAGCAAGTTCAATTCTTG
TCATTTATCAAAATATAAATGATATAATTTAATTAGGTAAAATAAAGA
ATTGCAAATTCTTGAATTCTCAGTTCAAATCTGAGTATCATTTTTTATA
AAAAGGATGTGGTGAAATTTGGTAAACACAGCGGACTT 
 
B1-463:           
CGGAGTTCTTCCCAGACGTGGATTTCCGTTGGTTCCGCCTCCTTCGTCC
GTCGTAATATCAGGCCTTCTGTTCTGTTCGCTGTCTGTCTAGGGCACCC
TTACTGCAAGAGAAGTATTTGAGGTCATATCGTCCCATGAAGTCGACC
ACCTGTTTCCTCTCTTCACTGTCACGTACGACATCGCATTCAAGGGAAG
AGATCCAGCAGATCTCGTTCGTGTATTCGAGACAAGAGAGGTCCGCCC
CCACAAGACGGCTGAAGAATGCAACATTCTTGTGCTGCCTCCTCTCAT
GGCAAATGCCAGAAGAAGGGTACGTGTTGCATCATAACAAGAGCTGT
ATTTCCCGCTGGCAAATACAGGTGAAATGTACCTCCAGAAAAGCCACC
TAGTATCGTGCGGCAATGTGCCACCTCGCCTCTTGGGAGAAAAAGAGG
AAGAGACGCTGCCGCTGTTTTGCAAATGA 
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SAG1-449(TgCatBr1) 
ACGAGTATGTTTCCGAAGGCAGTGAGACGCGCCGTCACGGCAGGGGT
GTTTGCCGCGCCCACACTGATGTCGTTCTTGCGATGTGGCGTTATGGCA
TCGGATCCCCCTCTTGTTGCCAATCAAGTTGTCACCTGCCCAGATAAAA
AATCGACAGCCGCGGTCATTCTCACACCGACGGAGAACCACTTCACTC
TCAAGTGCCCTAAAACAGCGCTCACAGAGCCTCCCACTCTTGCGTACT
CACCCAACAGGCAAATCTGCCCAGCGGGTACTACAAGTAGCTGTACAT
CAAAGGCTGTAACATTGAGCTCCTTGATTCCTGAAGCAGAAGATAGCT
GGTGGACGGGGGATTCTGCTAGTCTCGACACGGCAGGCATCAAACTCA
CAGTTCCAATCGAGAAGTTCCCCGTGACAACGCAGACGTTTGTGGTCG
GTTGCATCAAGGGAGA 
 
 
SAG2: 
GCCACCTCGAACAGGAACACAAAGGGAACAGAAATGTTTCAGGTTGC
TGCAGTGACCCATCTGCGAAGAAAACGAGCGCTGCTTGCGATTCTGTG
TGTTGTTTCACGGGTTGCAGTTCTAGGAACTGAGTTGTGATTGTGCACA
ATTGCGGTGTGACACCTTCTGTCTCGTTCCAATCTTTGTCTTGTCGGAA
CTATGAGTTTCTCAAAGACCACGAGCCTAGCGTCGCTAGCGCTCACGG
GCTTGTTTGTTGTGTTCAAGTTCGCTCTTGCGTCCACCACCGAGACGCC
AGCGCCCATTGAGTGCACTGCCGGCGCAACGAAGACTGTTGAGGC 
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GRA6 type I and type II polymorphisms demonstrating restriction cut sites 
Predicted PCR product (ME49)(typeII) 
TTTCCGAGCAGGTGACCTGGGTCGCTTTTTTGAAACAGCAGGAAAACA
GCTTCGTGGTGCCACGTAGCGTGCTTGTTGGCGACTACCTTTTTTTCTT
GGGAGTGTCGGCGAAATGGCACACGGTGGCATCTATCTGAGGCAGAA
GCGTAACTTCTGTCCTT^TAACTGTCTCCACAGTTGCTGTGGTCTTTGTA
GTCTTCATGGGTGTACTCGTCAATTCGTTGGGTGGAGTCGCTGTCGCAG
CAGACAGCGGTGGTGTTAGGCAGACCCCTTCGGAAACCGGTTCGAGCG
GTGGACAGCAAGAAGCAGTGGGGACCACTGAAGACTATGTCAACTCT
TCGGCGA 
 
L33814.1  GI:609619 (Type1) 
TTTCCGAGCAGGTGACCTGGGTCGCTTTTTTGAAACAGCAGGAAAACA
GCTTCGTGGTGCCACGTAGCGTGCTTGTTGGCGACTACCTTTTTTTCTT
GGGAGTGTCGGCGAAATGGCACACGGTGGCATCCATCTGAGGCAGAA
GCGTAACTTCTGTCCTGTAACTGTCTCCACAGTTGCTGTGGTCTTTGTA
GTCTTCATGGGTGTACTCGTCAATTCGTTGGGTGGAGTCCGTGTCGCAG
CAGACAGCGGTGGTGT^TAAGCAGACCCCTTCGGAAACCGGTTCGAGC
GGTGGACAGCAAGAAGCAGTGGGGACCACTGAAGACTATGTCAACTC
TTCGGCGA 
 
X96720.1  GI:1255983 (Type1) 
TTTCCGAGCAGGTGACCTGGGTCGCTTTTTTGAAACAGCAGGAAAACA
GCTTCGTGGTGCCACGTAGCGTGCTTGTTGGCGACTACCTTTTTTTCTT
GGGAATGTCGGCGAAATGGCACACGGTGGCATCCATCTGAGGCAGAA
GCGTAACTTCTGTCCTGTAACTGTCTCCACAGTTGCTGTGGTCTTTGTA
GTCTTCATGGGTGTACTCGTCAATTCGTTGGGTGGAGTCGCTGTCGCAG
CAGACAGCGGTGGTGT^TAAGCAGACCCCTTCGGAAACCGGTTCGAGC
GGTGGACAGCAAGAAGCAGTGGGGACCACTGAAGACTATGTCAACTC
TTCGGCGA 
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Appendix 3 – Sequencing results 
 
P30F Pork1 extraction: Positive T. gondii result. 
 
Nr megablast result: AF110182 Toxoplasma gondii major surface antigen p30 gene, 
partial cds 
E Value: 2.92e-23 Grade:99.9% Hit:265-326 
 
SAG1F Pork1 
 
Nr megablast result: no matches found 
 
SAG1R Pork1 extraction: 
 
 
 
P30F beef1 extraction: 
 
Nr megablast result: K00133 bovine 1.711 g/ml satellite dna, f fragment 
    105 
E value: 1.56e-11 Grade:63.0% Hit:636-676 
 
P30R beef1 extraction: 
 
Nr megablast result: No match found 
 
P30F Lamb1 extraction 
 
Nr megablast result: K00133 bovine 1.711 g/ml satellite dna, f fragment 
E value: 4.33e-12 Grade: 63.9% Hit: 635-676 
 
 
 
Pork1 P30F: 
 
Nr megablast result: K00133 bovine 1.711 g/ml satellite dna, f fragment 
E value: 4.33e-12 Grade:63.9% Hit:635-676 
 
 
 
    106 
Pork1 P30R: 
 
No blast query carried out due to poor quality. 
 
 
 
 
 
 
 
Beef API-F extraction  
 
Nr megablast result: AC150847 Bos taurus BAC CH240-372I17 (Children's Hospital 
Oakland Research Institute Bovine BAC Library complete sequence 
E value= 2.97e-19 Grade=48.6% Hit: 103175-103245 
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Lamb API-F extraction 
 
Nr megablast result: XM_005688682 PREDICTED: Capra hircus retinoblastoma-like 1 
(p107) (RBL1), mRNA 
E value:4.17e-47 Grade=87.4% Hit: 4944-4794 
 
Contaminated SAG1 nest: 
Beef5 449 R extraction 
 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value:2.26e-163 Grade = 100% Hit: 586-271 
    108 
Contaminated SAG1 nest 
Beef5 SAG1 F extraction 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value:2.27e-137 Grade=99.8% Hit:361-629 
 
 
 
 
 
 
 
 
 
 
 
    109 
contaminated SAG1 nest 
 
Lamb5 449F extraction 
 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value:1.45e-145 Grade=100% Hit:554-271 
 
 
 
 
 
 
 
 
 
 
    110 
Contaminated SAG1 nest 
 
Lamb5 SAGF extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value:1.28e-135 Grade=99.8% Hit:364-629 
 
 
 
 
 
 
 
 
 
 
    111 
Contaminated SAG1 nest 
 
Pork5 449R extraction: 
 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value:2.22e-143 Grade:100% Hit: 563-284 
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Contaminated SAG1 nest 
 
Pork5 SAGF extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value: 1.27e-135 Grade:99.8% Hit:364-629 
 
 
 
 
 
 
 
 
 
 
    113 
SAG nest, dubious result: 
Beef6 449R: 
 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value: 2.07e-138 Grade:100% Hit:539-269 
 
 
 
 
 
 
 
 
 
 
 
    114 
SAG nest, dubious result 
Beef6 SAG1F (extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E:1.22e-135 Grade:100% Hit:364-629 
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SAG nest, dubious result 
Lamb6 449R extraction: 
 
Nr megablast hit: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value:7.41e-138 Grade=100% Hit:540-271 
 
Lamb6 SAGF extraction 
 
    116 
Nr megablast result: GQ253080 Toxoplasma gondii strain RMS-1999-BES major surface 
antigen (SAG1) gene, complete cds 
E value: 4.08e-125 Grade:100% Hit:405-651 
 
SAG nest, dubious result 
Beef7 449F extraction: 
 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value: 4.62e-145 Grade:100% Hit:554-272 
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SAG nest, dubious result 
Beef7 SAGF extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value: 5.60e-134 Grade:100% Hit:364-626 
 
SAG nest, dubious result 
Lamb7 449R extraction 
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Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value 2.07e-138 Grade:100% Hit:539-269 
 
 
SAG nest, dubious result 
Lamb7 SAGF extraction: 
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Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value: 1.56e-134 Grade:100% Hit:364-627 
 
 
 
 
 
 
 
 
 
16-9-14 Meat5 contaminated: 
Beef5449R: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value:3.15e-120 Grade:100% Hit:520-283 
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Beef5 SAGF extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value:4.32e-129 Grade:100% Hit:364-617 
 
Chicken5 449R extraction: 
 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
    121 
E value:9.42e-131 Grade:100% Hit:538-282 
 
 
Chicken5 SAGF extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value:2.59e-127 Grade:100% Hit: 364-614 
 
Lamb5 449R extraction: 
 
    122 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
E value: 5.35e-123 Grade:100% Hit: 515-273 
 
 
 Lamb5 SAG F extraction: 
 
Nr megablast result: AK317969 Toxoplasma gondii cDNA, clone: XTG02220.2, full cDNA, 
XTG Sugano cDNA library 
 
Pork5 449R extraction: 
 
    123 
Nr megablast result: GQ253073 Toxoplasma gondii strain RMS-1994-LEF major surface 
antigen (SAG1) gene, complete cds 
E value 5.91e-138 Grade:100% Hit:554-285 
 
 
 
21-1-14 AF amplification: 
AF-f (extraction) 
 
Nr megablast result: No matches found 
AF-r(extraction) 
 
Nr megablast result: No matches found 
 
31-3-15: API Beef 
Beef API-F: 
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Nr megablast result: XM_005688682 PREDICTED: Capra hircus retinoblastoma-like 1 
(p107) (RBL1), mRNA 
E value: 8.58e-47 Grade:80.6% Hit:4944-4794 
Beef API-R 
 
Nr megablast result: AC150847 Bos taurus BAC CH240-372I17 (Children's Hospital 
Oakland Research Institute Bovine BAC Library complete sequence 
E value: 1.42e-24 Grade:68.6% Hit:103273-103175 
 
23-4-14 API-184 
Beef API184 F extraction 
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Nr megablast result: No match found 
 
 
Beef API 184 R extraction 
 
Nr megablast result: No matches found 
Lamb API 184 F: 
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Nr megablast result- no matches found 
Lamb API 184 R extraction: 
 
Nr megablast result: no matches found 
 
 
 
Beef L358 F (no extraction) 
 
    127 
Nr megablast result: No matches found 
Result appears to show multiple overlaid sequences- ie: multiple products 
 
Lamb L358 F extraction: 
 
Nr megablast result: AC169534 Bos taurus Y Chr BAC CH240-237I9 (Children's Hospital 
Oakland Research Institute Bovine BAC Library (male)) complete sequence 
E value: 3.53e-47 Grade:86.9% Hit:41561-41836 
 
Pork L358 F extraction: 
    128 
 
Nr megablast result: No matches found 
 Pork L358 R extraction: 
 
Nr megablast result: No matches found. 
Result appears to show multiple overlaid sequences- ie: multiple products 
 
 
 
 
Pork1 P30 F extraction: 
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Nr megablast result: AF110182 Toxoplasma gondii major surface antigen p30 gene, 
partial cds 
E value:2.92e-23 Grade:99.9% Hit:265-326 
 
Pork P30R- Null result 
 
Pork SAG F: 
 
No blast search carried out. 
Pork SAG R extraction: 
 
Nr megablast result: No matches found 
 
 
 
 
 
 
 
    130 
Beef SAG449 SAG1 nest: 
 nest B SAGF: 
Null result 
Beef SAG nest B SAGR extraction: 
 
Nr megablast result: No matches found 
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Appendix 3 – Nanodrop Results From Meat DNA 
Extractions 
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